<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedWorm: Obesity News</title>
        <description>MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Obesity</description>
        <link><![CDATA[https://medworm.com/obesity/news/]]></link>
        <lastBuildDate>Thu, 06 Jun 2024 18:59:50 +0100</lastBuildDate>
        <item>
            <title>Here are Thursday's biggest analyst calls: Apple, Nvidia, Tesla, Netflix, Alphabet, United, JPMorgan, Carvana, Broadcom &amp;  more</title>
            <link>https://medworm.com/1213867539/here-are-thursday-s-biggest-analyst-calls-apple-nvidia-tesla-netflix-alphabet-united-jpmorg/</link>
            <description>Here are the biggest calls on Wall Street on Thursday: Morgan Stanley reiterates Tesla as overweight Morgan Stanley said that despite Tesla&amp;#39;s volatility, it&amp;#39;s sticking with its overweight rating on the stock. &amp;#34; Tesla April global EV share fell to 12% vs. 19% last month and 17% YTD. China tariff…#tesla #oppenheimer #walmart #atoppick #apple #goldmansachs #nvidia #goldman #diamondbackenergy #midland (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213867539</guid>        </item>
        <item>
            <title>The Popular Sugar Substitute Xylitol Could Have Some Major Heart-Health Risks</title>
            <link>https://medworm.com/1213868922/the-popular-sugar-substitute-xylitol-could-have-some-major-heart-health-risks/</link>
            <description>Losing weight is one the best ways to lower your risk of heart disease, and cutting back on sugar can contribute to that. But sweeteners that mimic the taste of sugar with fewer&amp;mdash;or no&amp;mdash;calories could be increasing, rather than decreasing, the risk of some heart events.



In a study published Thursday in the European Heart Journal, an international group of researchers led by a team at the Cleveland Clinic report that higher levels of xylitol, a sugar substitute found in candy and even toothpaste, are linked to a higher risk of heart attack, stroke, and death.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




The study included more than 3,000 people in the U.S. and Europe, about half of whom had a history of heart disease, and almost all of whom had at least a few risk factors f...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213868922</guid>        </item>
        <item>
            <title>Fine Particulate Matter Raises Type 2 Diabetes Risk in Women Fine Particulate Matter Raises Type 2 Diabetes Risk in Women</title>
            <link>https://medworm.com/1213851038/fine-particulate-matter-raises-type-2-diabetes-risk-in-women-fine-particulate-matter-raises-type-2-d/</link>
            <description>Long-term exposure to fine particulate matter increased type 2 diabetes in women of childbearing age, particularly those with overweight/obesity or over 35 years of age.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213851038</guid>        </item>
        <item>
            <title>Overweight teens, young adults face greater stroke risk later, study says</title>
            <link>https://medworm.com/1213868632/overweight-teens-young-adults-face-greater-stroke-risk-later-study-says/</link>
            <description>Women who harbor excess weight as teens or young adults may face a higher risk of a clot-caused stroke by age 55, while men do not, a new study finds. (Source: Health News - UPI.com)</description>
            <author>Health News - UPI.com</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213868632</guid>        </item>
        <item>
            <title>Dangerously obese people to be offered new powerful weight loss jab on NHS</title>
            <link>https://medworm.com/1213584232/dangerously-obese-people-to-be-offered-new-powerful-weight-loss-jab-on-nhs/</link>
            <description>The injection could help people lose a fifth of their body weight, according to trials. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213584232</guid>        </item>
        <item>
            <title>Mounjaro is second obesity drug to be approved for use in England</title>
            <link>https://medworm.com/1213432061/mounjaro-is-second-obesity-drug-to-be-approved-for-use-in-england/</link>
            <description>Those with BMI of 35 and a comorbidity can now be prescribed tirzepatide and Nice says it is more effective than WegovyThe medical treatment regulator for England has approved a second drug to combat obesity, giving patients and doctors what it says is a more effective alternative tosemaglutide.The National Institute for Health and Care Excellence (Nice) issued draft guidance on Tuesday recommending that very obese peopleshould be prescribed tirzepatide, which is marketed in the UK as Mounjaro.Continue reading... (Source: Guardian Unlimited Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213432061</guid>        </item>
        <item>
            <title>Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancers</title>
            <link>https://medworm.com/1213395508/weight-loss-jabs-have-enormous-potential-to-cut-risk-of-obesity-related-cancers/</link>
            <description>The revolutionary jabs were a hot topic as more than 40,000 cancer experts gathered in Chicago for the world's largest cancer conference. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213395508</guid>        </item>
        <item>
            <title>‘Enormous potential’: weight-loss drugs cut cancer risk by a fifth, research shows</title>
            <link>https://medworm.com/1213432064/enormous-potential-weight-loss-drugs-cut-cancer-risk-by-a-fifth-research-shows/</link>
            <description>Experts believe injections such as Wegovy could play a big role in preventing and treating the diseaseWeight-loss drugs offer a new weapon in the global fight against cancer, with “enormous potential” to prevent new cases and shrink tumours, doctors said as research showed the jabs can cut the risk of developing the disease by a fifth.Blockbuster injections such as Wegovy have revolutionised the treatment of obesity, and recently been approved for use in other areas of medicine, including reducing the risk of heart attacks, strokes and cardiovascular-related deaths.Continue reading... (Source: Guardian Unlimited Science)</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213432064</guid>        </item>
        <item>
            <title>Britain Considers Offering Lilly Weight-loss Drug on Better Terms Than Wegovy Britain Considers Offering Lilly Weight-loss Drug on Better Terms Than Wegovy</title>
            <link>https://medworm.com/1213566263/britain-considers-offering-lilly-weight-loss-drug-on-better-terms-than-wegovy-britain-considers-offe/</link>
            <description>Britain's medical costs regulator on Tuesday recommended Eli Lilly's weight-loss drug Mounjaro for some patients with obesity and suggested not placing a time limit on the...Reuters Health Information (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213566263</guid>        </item>
        <item>
            <title>' Ozempic Burgers' Offer Indulgences to People With Obesity'Ozempic Burgers' Offer Indulgences to People With Obesity</title>
            <link>https://medworm.com/1213374330/-ozempic-burgers-offer-indulgences-to-people-with-obesity-ozempic-burgers-offer-indulgences/</link>
            <description>Nestl é recently announced they would sell food targeted for customers on anti-obesity medications. Yoni Freedhoff, MD, explains why this move should be celebrated.Medscape Diabetes &amp; Endocrinology (Source: Medscape Pharmacist Headlines)</description>
            <author>Medscape Pharmacist Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213374330</guid>        </item>
        <item>
            <title>'King Kong' weight loss jab set to be free on the NHS: spending watchdog gives green light to powerful new drug Mounjaro, a year after refusing to approve it</title>
            <link>https://medworm.com/1213298744/king-kong-weight-loss-jab-set-to-be-free-on-the-nhs-spending-watchdog-gives-green-light-to-powerf/</link>
            <description>Draft guidance by the UK's drugs watchdog, NICE has now urged mounjaro's usage to be expanded for weight loss in those severely obese. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213298744</guid>        </item>
        <item>
            <title>Excess Weight Over Time Increases Risk for Heart Attack Excess Weight Over Time Increases Risk for Heart Attack</title>
            <link>https://medworm.com/1213282593/excess-weight-over-time-increases-risk-for-heart-attack-excess-weight-over-time-increases-risk-for-h/</link>
            <description>Adults under 50 years who lived with obesity for a decade were up to 60% more likely to experience a cardiovascular event.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213282593</guid>        </item>
        <item>
            <title>Should Wegovy, the $400-a-month obesity medication, be covered by the provinces?</title>
            <link>https://medworm.com/1213204473/should-wegovy-the-400-a-month-obesity-medication-be-covered-by-the-provinces/</link>
            <description>The blockbuster weight-loss drug Wegovy has been available in Canada since early May, but anybody hoping to use it will have to shell out about $400 a month. The scientific director of Obesity Canada says that lack of coverage will cost the country in the long run. (Source: CBC | Health)</description>
            <author>CBC  | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213204473</guid>        </item>
        <item>
            <title>Structure Therapeutics Stock Soars On Weight-Loss Drug Results</title>
            <link>https://medworm.com/1213109422/structure-therapeutics-stock-soars-on-weight-loss-drug-results/</link>
            <description>Structure Therapeutics (GPCR) stock rocketed to a six-month high Monday after the biotech company delivered &amp;#34;compelling&amp;#34; results for its weight-loss drug. The company tested its drug over 12 weeks in patients with obesity but not type 2 diabetes. Patients who took the oral medicine lost 6.9% of…#leerinkpartners #davidrisinger #elililly #lly #lilly #marketsurge #allisongatlin #ibdagatlin #modernawinsfd #gsk (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213109422</guid>        </item>
        <item>
            <title>Overweight children have lower intelligence and are more likely to be depressed, controversial study finds</title>
            <link>https://medworm.com/1213109189/overweight-children-have-lower-intelligence-and-are-more-likely-to-be-depressed-controversial-study/</link>
            <description>Scientists in the US, who tracked more than 5,000 nine to 11-year-olds, found pupils with a higher body mass index (BMI) performed worse in tests. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213109189</guid>        </item>
        <item>
            <title>Structure's Obesity Pill Surpasses Expectations in Mid-stage Study Structure's Obesity Pill Surpasses Expectations in Mid-stage Study</title>
            <link>https://medworm.com/1213308232/structure-s-obesity-pill-surpasses-expectations-in-mid-stage-study-structure-s-obesity-pill-surp/</link>
            <description>Structure Therapeutics said on Monday its experimental oral obesity drug helped reduce weight by 6.2% on average in a mid-stage study, exceeding Wall Street expectations and...Reuters Health Information (Source: Medscape FamilyMedicine Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape FamilyMedicine Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213308232</guid>        </item>
        <item>
            <title>GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy</title>
            <link>https://medworm.com/1213106551/glp-1-weight-loss-meds-might-keep-your-pancreas-healthy/</link>
            <description>MONDAY, June 3, 2024 -- Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says.Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213106551</guid>        </item>
        <item>
            <title>Ultra-processed food and obesity could be behind 'disturbing' rise in cancer hitting young people, warn UK's top doctors</title>
            <link>https://medworm.com/1213014869/ultra-processed-food-and-obesity-could-be-behind-disturbing-rise-in-cancer-hitting-young-people-w/</link>
            <description>More young people than ever are getting cancer, with diagnosis rates rising by a quarter in two decades. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213014869</guid>        </item>
        <item>
            <title>Doctors' Tips for Accessing Costly GLP-1 Therapies Doctors' Tips for Accessing Costly GLP-1 Therapies</title>
            <link>https://medworm.com/1213015466/doctors-tips-for-accessing-costly-glp-1-therapies-doctors-tips-for-accessing-costly-glp-1-ther/</link>
            <description>Injectable anti-obesity drugs can run close to $1000 per month, so patients rely on physicians to find affordable pharmacy options.Medscape Medical News (Source: Medscape Medical News Headlines)</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1213015466</guid>        </item>
        <item>
            <title>Semaglutide May Boost Taste Sensitivity</title>
            <link>https://medworm.com/1212893464/semaglutide-may-boost-taste-sensitivity/</link>
            <description>(MedPage Today) -- BOSTON -- Once-weekly semaglutide (Ozempic, Wegovy) improved taste sensitivity, changed gene expression in the tongue linked to taste perception, and changed brain activity in response to sweet tastes in women with obesity... (Source: MedPage Today Cardiovascular)</description>
            <author>MedPage Today Cardiovascular</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212893464</guid>        </item>
        <item>
            <title>GLP-1 Coverage Often Denied for Teens With Obesity GLP-1 Coverage Often Denied for Teens With Obesity</title>
            <link>https://medworm.com/1212900129/glp-1-coverage-often-denied-for-teens-with-obesity-glp-1-coverage-often-denied-for-teens-with-obesit/</link>
            <description>Half of adolescents who did fill prescriptions never reached their treatment dose, according to a single-center retrospective study.Medscape Medical News (Source: Medscape Pharmacist Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Pharmacist Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212900129</guid>        </item>
        <item>
            <title>Semaglutide Improves Taste Sensitivity in Women With Obesity Semaglutide Improves Taste Sensitivity in Women With Obesity</title>
            <link>https://medworm.com/1212808715/semaglutide-improves-taste-sensitivity-in-women-with-obesity-semaglutide-improves-taste-sensitivity-/</link>
            <description>Women taking the medication after 16 weeks better sensed lower concentrations of flavors and had notable changes in brain responses to sweet stimuli.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212808715</guid>        </item>
        <item>
            <title>Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says</title>
            <link>https://medworm.com/1212730552/eli-lilly-s-wegovy-rival-zepbound-will-help-make-weight-loss-drug-market-worth-130-billion-by-203/</link>
            <description>None The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs said. • None New products such as Eli Lilly&amp;#39;s Zepbound prompted the bank to raise its forecast. • None The FDA approved the pharma giant&amp;#39;s new weight-loss drug in November. The market for weight-loss drugs such as…#goldmansachs #elililly #fda #ozempic #wegovy #zepbound #danish #novonordisk #chrisshibutani #eli (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212730552</guid>        </item>
        <item>
            <title>Weight-loss jabs like Wegovy and Ozempic reduce risk of some of the most common and deadly cancers, study suggests</title>
            <link>https://medworm.com/1212730338/weight-loss-jabs-like-wegovy-and-ozempic-reduce-risk-of-some-of-the-most-common-and-deadly-cancers-/</link>
            <description>After smoking, obesity is thought to be the second most common cause of cancer in the UK and is responsible for around one in 20 new cases every year. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212730338</guid>        </item>
        <item>
            <title>Morgan Stanley survey sees Tesla investors voting to ratify Elon Musk ’s 2018 comp plan</title>
            <link>https://medworm.com/1212540494/morgan-stanley-survey-sees-tesla-investors-voting-to-ratify-elon-musk-s-2018-comp-plan/</link>
            <description>Morgan Stanley analyst Adam Jonas has reiterated his “Overweight” rating and $310 per share price target for electric vehicle maker Tesla (NASDAQ:TSLA). In his comments, the analyst discussed Tesla’s upcoming 2024 Annual Stockholders’ Meeting, as well as the potential results of the vote…#adamjonas #overweight #tesla #elonmusks #delaware #elonmusk #morganstanleys (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212540494</guid>        </item>
        <item>
            <title>Ultra-processed foods do NOT cause obesity, says US government's top diet advisors in bombshell review of current evidence: 'Studies have been biased'</title>
            <link>https://medworm.com/1212353097/ultra-processed-foods-do-not-cause-obesity-says-us-governments-top-diet-advisors-in-bombshell-revi/</link>
            <description>A new report from the USDA suggests that the evidence linking ultra processed foods to obesity is flimsy. The top nutritionists recommend more research on the topic . (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212353097</guid>        </item>
        <item>
            <title>Exasperated Brianna Keilar Scolds Guests for Needing ‘Fact Check’ and ‘Fat-Shaming’ Trump: ‘Can We Just Have a Decent Conversation?’</title>
            <link>https://medworm.com/1212353337/exasperated-brianna-keilar-scolds-guests-for-needing-fact-check-and-fat-shaming-trump-/</link>
            <description>CNN’s Brianna Keilar wanted to be anywhere but talking to Paul Begala and Hogan Gidley on Friday. Begala, a longtime Democratic operative, took a victory lap the day after former President Donald Trump was convicted in New York for falsifying business records. He called Trump “an obese, flatulent…#briannakeilar #paulbegala #hogangidley #donaldtrump #trump #obese #stormydaniels #joebidens #keilar #borissanchez (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212353337</guid>        </item>
        <item>
            <title>‘Obese Flatulent Old Man’: CNN Analyst Says He Pities Trump For Having to Endure Trial Where Porn Star Testified ‘How Bad He Is In Bed’</title>
            <link>https://medworm.com/1212353394/obese-flatulent-old-man-cnn-analyst-says-he-pities-trump-for-having-to-endure-trial-where-por/</link>
            <description>CNN analyst Paul Begala roasted Donald Trump as a “obese flatulent old man” with “bad makeup and weird hair” while discussing his conviction at the hush money trial in New York. Begala noted during a CNN interview on Friday that he pities Trump for having to sit in a courtroom over the last…#paulbegala #donaldtrump #obese #trump #manhattan #stormydaniels #alvinbragg #maga #medicare #socialsecurity (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212353394</guid>        </item>
        <item>
            <title>Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24</title>
            <link>https://medworm.com/1212321718/tirzepatide-sheds-pounds-in-chinese-adults-with-bmi-as-low-as-24/</link>
            <description>(MedPage Today) -- Tirzepatide (Zepbound) was effective at reducing body weight in Chinese adults with lower cutoffs for overweight or obesity, the SURMOUNT-CN trial reported.
In the study of 210 adults without diabetes, participants on tirzepatide... (Source: MedPage Today Public Health)</description>
            <author>MedPage Today Public Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212321718</guid>        </item>
        <item>
            <title>How your sexual preference can raise your chance of multiple CANCERS, according to first-of-its-kind report</title>
            <link>https://medworm.com/1212353102/how-your-sexual-preference-can-raise-your-chance-of-multiple-cancers-according-to-first-of-its-kind/</link>
            <description>A first-of-its-kind report from the American Cancer Society found that lesbian, gay, bisexual and transgender individuals are more likely to smoke, drink alcohol and be obese, raising cancer risk. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212353102</guid>        </item>
        <item>
            <title>BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults</title>
            <link>https://medworm.com/1212362287/bmi-cutoff-of-30-for-obesity-may-be-too-high-for-middle-aged-older-adults/</link>
            <description>FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented at the annual meeting of the European Congress on Obesity, hosted by... (Source: Drugs.com - Pharma News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212362287</guid>        </item>
        <item>
            <title>Bariatric Surgery May Reduce Breast Cancer Risk for Some Bariatric Surgery May Reduce Breast Cancer Risk for Some</title>
            <link>https://medworm.com/1212239817/bariatric-surgery-may-reduce-breast-cancer-risk-for-some-bariatric-surgery-may-reduce-breast-cancer-/</link>
            <description>Bariatric surgery was associated with a lower risk for breast cancer in women with obesity who had higher baseline insulin levels or who were premenopausal, new data suggested.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212239817</guid>        </item>
        <item>
            <title>South Park's Ozempic Episode Took A Shot At Lizzo</title>
            <link>https://medworm.com/1212257193/south-park-s-ozempic-episode-took-a-shot-at-lizzo/</link>
            <description>It definitely seems like &amp;#34;South Park&amp;#34; is commenting on the quality of Lizzo&amp;#39;s music. At various points in the special, individuals who listen to her songs defecate out of their ears. Still, the inclusion of Lizzo in &amp;#34;South Park: The End of Obesity&amp;#34; was a means to an end, namely offering a broader…#southpark #paramount #exactlyhowifeel (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212257193</guid>        </item>
        <item>
            <title>What Raises the Risk for Early Puberty in Girls? What Raises the Risk for Early Puberty in Girls?</title>
            <link>https://medworm.com/1212048781/what-raises-the-risk-for-early-puberty-in-girls-what-raises-the-risk-for-early-puberty-in-girls/</link>
            <description>In Chinese girls, a mix of overweight/obesity, limited physical activity, and excessive screen time raised the risk for EPD, with excess weight alone or in combination being the biggest factor.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212048781</guid>        </item>
        <item>
            <title>Novel Score Predicts Weight Loss With Semaglutide in T2D Novel Score Predicts Weight Loss With Semaglutide in T2D</title>
            <link>https://medworm.com/1212048782/novel-score-predicts-weight-loss-with-semaglutide-in-t2d-novel-score-predicts-weight-loss-with-semag/</link>
            <description>The individualized metabolic surgery score could help set realistic weight loss targets with semaglutide in patients with type 2 diabetes and obesity.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1212048782</guid>        </item>
        <item>
            <title>Millions of Brits could be labelled 'obese' under new BMI guidelines</title>
            <link>https://medworm.com/1211971429/millions-of-brits-could-be-labelled-obese-under-new-bmi-guidelines/</link>
            <description>A proposed revamp of the BMI system could see millions of Brits being classified as obese, as experts warn the current guidelines are failing to identify those at risk (Source: Daily Express - Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211971429</guid>        </item>
        <item>
            <title>Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?</title>
            <link>https://medworm.com/1211718686/millions-of-americans-need-drugs-like-ozempic-will-it-bankrupt-the-healthcare-system/</link>
            <description>Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study. (Source: Los Angeles Times - Science)</description>
            <author>Los Angeles Times - Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211718686</guid>        </item>
        <item>
            <title>Add-On to GLP-1s Yields Greater Weight Loss Add-On to GLP-1s Yields Greater Weight Loss</title>
            <link>https://medworm.com/1211665412/add-on-to-glp-1s-yields-greater-weight-loss-add-on-to-glp-1s-yields-greater-weight-loss/</link>
            <description>Combination therapy of bupropion/naltrexone and GLP-1 receptor agonists showed a synergistic weight loss effect in individuals with obesity who responded poorly to GLP-1 monotherapy.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211665412</guid>        </item>
        <item>
            <title>Sugar Traders In Denial As Ozempic Craze Ramps Up</title>
            <link>https://medworm.com/1211586336/sugar-traders-in-denial-as-ozempic-craze-ramps-up/</link>
            <description>The junk-food industrial complex is on notice after pumping American consumers with sugars and carbs for decades, sparking an obesity crisis that has weighed on the nation&amp;#39;s healthcare system. Remarkably, big pharma&amp;#39;s response to the obesity crisis…#goldman #sallylyonswyatt #circana #newyorksugardinner #wyatt #obese #glp1 #pamelakaufman #konahaque #edfman (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211586336</guid>        </item>
        <item>
            <title>Not All COVID Patients Benefit From JAK Inhibitor</title>
            <link>https://medworm.com/1211507662/not-all-covid-patients-benefit-from-jak-inhibitor/</link>
            <description>(MedPage Today) -- People randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial only saw a survival benefit if they had obesity, a post-hoc analysis found.
Death within 28 days of... (Source: MedPage Today Rheumatology)</description>
            <author>MedPage Today Rheumatology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211507662</guid>        </item>
        <item>
            <title>How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use?</title>
            <link>https://medworm.com/1211473118/how-many-ditch-glp-1-drugs-more-weekly-insulin-data-ozempic-for-alcohol-use/</link>
            <description>(MedPage Today) -- At 12 months, 36.5% of people had discontinued their GLP-1 receptor agonist in a study of nearly 200,000 adults with obesity with or without type 2 diabetes. (JAMA Network Open)
In a phase Ib trial, a once-weekly injection of... (Source: MedPage Today Endocrinology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Endocrinology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211473118</guid>        </item>
        <item>
            <title>Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease</title>
            <link>https://medworm.com/1211595419/semaglutide-boosts-kidney-outcomes-with-obesity-cardiovascular-disease/</link>
            <description>TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study presented at the annual European Renal Association... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211595419</guid>        </item>
        <item>
            <title>Obesity and Cancer: Untangling a Complex Web Obesity and Cancer: Untangling a Complex Web</title>
            <link>https://medworm.com/1211457991/obesity-and-cancer-untangling-a-complex-web-obesity-and-cancer-untangling-a-complex-web/</link>
            <description>Although more than 40% of cancers are considered obesity-related, excess weight is often just a contributing risk factor, leaving uncertainty about the role weight plays in cancer risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)</description>
            <author>Medscape Hematology-Oncology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211457991</guid>        </item>
        <item>
            <title>How Can Patients With Diabetes and Obesity Lose Weight? How Can Patients With Diabetes and Obesity Lose Weight?</title>
            <link>https://medworm.com/1211473140/how-can-patients-with-diabetes-and-obesity-lose-weight-how-can-patients-with-diabetes-and-obesity-l/</link>
            <description>At a recent diabetes conference, experts debated the relative merits of exercise and medication for weight loss in this patient population.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211473140</guid>        </item>
        <item>
            <title>Lizzo's proud to have made a big enough name for herself to get mentioned in'South Park '</title>
            <link>https://medworm.com/1211392203/lizzo-s-proud-to-have-made-a-big-enough-name-for-herself-to-get-mentioned-in-south-park-/</link>
            <description>None Lizzo&amp;#39;s name was mentioned in the &amp;#34;South Park: The End of Obesity&amp;#34; special. • None Characters in the series claim the new &amp;#34;Lizzo&amp;#34; drug helps patients overcome weight-loss worries. • None Lizzo was the subject of a lawsuit filed last year claiming she shamed dancers over their weight. Lizzo is…#nonelizzo #southpark #nonecharacters #lizzo #truthhurts #colorado (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211392203</guid>        </item>
        <item>
            <title>Why Ozempic can help the rural health epidemic | Opinion</title>
            <link>https://medworm.com/1211303191/why-ozempic-can-help-the-rural-health-epidemic-opinion/</link>
            <description>Easing access to Ozempic, other weight loss drugs, is key to solving rural obesity crisis, writes former Missouri State Rep. Dan Shaul (Source: bizjournals.com Health Care:Pharmaceuticals headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>bizjournals.com Health Care:Pharmaceuticals headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211303191</guid>        </item>
        <item>
            <title>Obesity Research is Going to the Dogs</title>
            <link>https://medworm.com/1211234728/obesity-research-is-going-to-the-dogs/</link>
            <description>Gene mutations in rotund retrievers shed light on the neural regulation of body weight. (Source: The Scientist)</description>
            <author>The Scientist</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211234728</guid>        </item>
        <item>
            <title>Women advised to pair effective contraception with ‘skinny jabs’</title>
            <link>https://medworm.com/1211234674/women-advised-to-pair-effective-contraception-with-skinny-jabs/</link>
            <description>Amid baby boom reports linked to drugs such as Wegovy and Ozempic, experts say it would be ‘wise’ to take extra precautionsClaims that “skinny jabs” are fuelling an unexpected baby boom have led experts to warn women to pair their use with effective contraception.Medications such as Wegovy and Ozempic, both of which contain semaglutide, have become hugely popular, not least because they can help peoplelose more than 10% of their body weight.Continue reading... (Source: Guardian Unlimited Science)</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211234674</guid>        </item>
        <item>
            <title>How Metabolic Syndrome, Obesity Impact Breast Cancer Risk How Metabolic Syndrome, Obesity Impact Breast Cancer Risk</title>
            <link>https://medworm.com/1211163912/how-metabolic-syndrome-obesity-impact-breast-cancer-risk-how-metabolic-syndrome-obesity-impact-bre/</link>
            <description>New data from the Women's Health Initiative revealed that metabolic syndrome and obesity each have different associations with breast cancer incidence and mortality risk in postmenopausal women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)</description>
            <author>Medscape Hematology-Oncology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211163912</guid>        </item>
        <item>
            <title>Glucagon-like-peptide 1 receptor agonism and attempted suicide: a mendelian randomisation study to assess a potential causal association - Nguyen A, Smith E, Hashemy H, Agarwal SM, Hahn MK, Paterson AD, Dash S.</title>
            <link>https://medworm.com/1211123060/glucagon-like-peptide-1-receptor-agonism-and-attempted-suicide-a-mendelian-randomisation-study-to-a/</link>
            <description>Glucagon-like-peptide 1 receptor agonists (GLP-1RA) have transformed type 2 diabetes (T2D) and obesity management. Multiple regulatory agencies are investigating reported associations between GLP1-RA and increased suicide attempts (SA), but observational d... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211123060</guid>        </item>
        <item>
            <title>Semaglutide Aids Weight Loss in Those With IBD and Obesity Semaglutide Aids Weight Loss in Those With IBD and Obesity</title>
            <link>https://medworm.com/1211179206/semaglutide-aids-weight-loss-in-those-with-ibd-and-obesity-semaglutide-aids-weight-loss-in-those-wit/</link>
            <description>Semaglutide was equally effective for obesity in patients with or without IBD, with a more than 5% mean weight loss and no increased risk for disease-specific adverse events.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211179206</guid>        </item>
        <item>
            <title>See Lizzo ’s Reaction to ‘South Park’ Joke About Her in Ozempic Episode</title>
            <link>https://medworm.com/1211001034/see-lizzo-s-reaction-to-south-park-joke-about-her-in-ozempic-episode/</link>
            <description>Lizzo is sharing her thoughts on the new South Park episode. On Friday (May 24), the long-running animated comedy series released its latest special, titled “The End of Obesity,” through Paramount+. The episode takes aim at the Ozempic craze and uses the pop-rap star singer as an alternative to…#southpark #endofobesity #paramount #ericcartman #lizzofive #tiktok #colorado #goodashell #ariannadavis #crystalwilliams (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211001034</guid>        </item>
        <item>
            <title>Semaglutide Kidney Benefits Extend to Those Without Diabetes Semaglutide Kidney Benefits Extend to Those Without Diabetes</title>
            <link>https://medworm.com/1211001211/semaglutide-kidney-benefits-extend-to-those-without-diabetes-semaglutide-kidney-benefits-extend-to-t/</link>
            <description>The effects in an obese population without diabetes and low rates of kidney disease suggest a'potential role in the primary prevention of CKD. 'Medscape Medical News (Source: Medscape Medical News Headlines)</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211001211</guid>        </item>
        <item>
            <title>Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars</title>
            <link>https://medworm.com/1210608344/lilly-invests-further-53-billion-in-new-indiana-site-as-obesity-drug-demand-soars/</link>
            <description>Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs. The new investment, which brings the total to $9 billion, will…#elililly #lebanon #indiana #api #lilly #davidricks #iqvia #indianapolis #zepbound #concord (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210608344</guid>        </item>
        <item>
            <title>Eli Lilly will spend $5.3 billion to boost manufacturing capacity for its anti-obesity drug Zepbound and cousin diabetes drug Mounjaro</title>
            <link>https://medworm.com/1210510365/eli-lilly-will-spend-53-billion-to-boost-manufacturing-capacity-for-its-anti-obesity-drug-zepbound/</link>
            <description>(Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210510365</guid>        </item>
        <item>
            <title>World Heart Report: Air Pollution-Related Deaths From Heart Conditions, Obesity, Diabetes Are Growing —And Climate Change Partially To Blame</title>
            <link>https://medworm.com/1211009916/world-heart-report-air-pollution-related-deaths-from-heart-conditions-obesity-diabetes-are-growin/</link>
            <description>Around 70% of the over four million deaths related to outdoor air pollution in 2019 were caused by heart conditions, and global particulate matter concentrations were over six times higher than the recommended amount. (Source: Forbes.com Healthcare News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1211009916</guid>        </item>
        <item>
            <title>How junk food causes cancer - as Morgan Spurlock, maker of Super Size Me, dies from disease aged 53</title>
            <link>https://medworm.com/1210412165/how-junk-food-causes-cancer-as-morgan-spurlock-maker-of-super-size-me-dies-from-disease-aged-53/</link>
            <description>Mountains of research in recent decades have shown that eating lots of processed foods is linked to at least 34 different types of cancers - even in people who are not obese. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210412165</guid>        </item>
        <item>
            <title>Men like Scott Disick on Ozempic-like drugs are 3.5 times more likely to suffer embarrassing sexual side effect, first major study shows</title>
            <link>https://medworm.com/1210412167/men-like-scott-disick-on-ozempic-like-drugs-are-35-times-more-likely-to-suffer-embarrassing-sexual-/</link>
            <description>Researchers from the University of Texas studied more than 1,500 obese, non-diabetic men on the blockbuster drug and found a staggering number experienced sex problems. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210412167</guid>        </item>
        <item>
            <title>How OB/GYNs Can Help Patients Manage Weight How OB/GYNs Can Help Patients Manage Weight</title>
            <link>https://medworm.com/1210293965/how-obgyns-can-help-patients-manage-weight-how-obgyns-can-help-patients-manage-weight/</link>
            <description>What OB/GYNs should know about prescribing anti-obesity medications or simply providing their patients with information about the available drugs.MDedge News (Source: Medscape Pharmacist Headlines)</description>
            <author>Medscape Pharmacist Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210293965</guid>        </item>
        <item>
            <title>Strokes in under 45s have risen 15% in a decade, new CDC data show...amid young cancer spike</title>
            <link>https://medworm.com/1210215156/strokes-in-under-45s-have-risen-15-in-a-decade-new-cdc-data-showamid-young-cancer-spike/</link>
            <description>A new CDC report found that stroke cases are rising in America - with a particular focus on people under 45. This corresponds with a national increase in conditions like obesity. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210215156</guid>        </item>
        <item>
            <title>More Weight Loss With Anti-Obesity Meds and Hormone Therapy? More Weight Loss With Anti-Obesity Meds and Hormone Therapy?</title>
            <link>https://medworm.com/1210099605/more-weight-loss-with-anti-obesity-meds-and-hormone-therapy-more-weight-loss-with-anti-obesity-meds/</link>
            <description>Women who take hormone therapy showed a better response to GLP-1 drugs and lost more weight.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210099605</guid>        </item>
        <item>
            <title>Sleeve Gastrectomy Improves Kidney Transplant Rates Sleeve Gastrectomy Improves Kidney Transplant Rates</title>
            <link>https://medworm.com/1210099606/sleeve-gastrectomy-improves-kidney-transplant-rates-sleeve-gastrectomy-improves-kidney-transplant-ra/</link>
            <description>Sleeve gastrectomy leads to significant weight loss and improves eligibility for kidney transplant in adults with obesity and severe kidney disease.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210099606</guid>        </item>
        <item>
            <title>Epidural during labour associated with 35% reduced risk from complications: BMJ Study</title>
            <link>https://medworm.com/1210116497/epidural-during-labour-associated-with-35-reduced-risk-from-complications-bmj-study/</link>
            <description>Research in the British Medical Journal found that epidural during labour reduces the risk of severe maternal morbidity (SMM) by 35%. SMM includes heart attack, sepsis, and hysterectomy. Epidural analgesia is recommended for high-risk pregnancies due to obesity, multiple births, or premature delivery. (Source: The Economic Times)</description>
            <author>The Economic Times</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210116497</guid>        </item>
        <item>
            <title>Mayo scientists explore swabs for early endometrial, ovarian cancer detection  </title>
            <link>https://medworm.com/1210561880/mayo-scientists-explore-swabs-for-early-endometrial-ovarian-cancer-detection-/</link>
            <description>This 3D illustration shows cancerous cells in the female reproductive system. Early detection improves treatment outcomes for endometrial and ovarian cancers, yet far too often women are diagnosed in advanced stages of these diseases. Unlike many other cancers, there are no standard screenings for early detection of endometrial and ovarian cancers. The incidence rate for endometrial cancer is expected to rise, driven by environmental factors, obesity and diabetes. Marina Walther-Antonio, Ph.D., and colleagues at Mayo&amp;hellip; (Source: Mayo Clinic Minnesota News)</description>
            <author>Mayo Clinic Minnesota News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1210561880</guid>        </item>
        <item>
            <title>Bankrupt Red Lobster Proves &quot; All You Can Eat &quot;  In An Obese Country Isn't A Good Idea</title>
            <link>https://medworm.com/1209920402/bankrupt-red-lobster-proves-all-you-can-eat-in-an-obese-country-isn-t-a-good-idea/</link>
            <description>Bankrupt Red Lobster Proves &amp;#34;All You Can Eat&amp;#34; In An Obese Country Isn&amp;#39;t A Good Idea Red Lobster&amp;#39;s bankruptcy report is revealing details about how the chain, famous for trying to turn a profit selling &amp;#34;all you can eat&amp;#34; shrimp to a country that has gotten so fat it needs to occupy two seats on most…#allyoucaneat #agoodidea #redlobster #dardenrestaurants #paulkenny #thaiunion #tylerdurden (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209920402</guid>        </item>
        <item>
            <title>Use of Wegovy and other weight-loss drugs soars among kids and young adults</title>
            <link>https://medworm.com/1209920480/use-of-wegovy-and-other-weight-loss-drugs-soars-among-kids-and-young-adults/</link>
            <description>Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults (Source: ABC News: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>ABC News: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209920480</guid>        </item>
        <item>
            <title>As L.A. County nighttime recreation program expands scope, success largely continues</title>
            <link>https://medworm.com/1209844499/as-la-county-nighttime-recreation-program-expands-scope-success-largely-continues/</link>
            <description>Key takeawaysA survey of attendees in 2023 found that 93% felt safe at Parks After Dark.Of attendees who did not meet the recommended activity guidelines for their age, 76% participated in at least one exercise or sports program at Parks After Dark.The vast majority of those surveyed expressed high levels of satisfaction with 97% saying they would attend again.Leer en espa ñol.Parks After Dark, the free Los Angeles County program that provides a safe space for people primarily during evening hours, fosters stronger feelings of community and closer connections among neighbors, according to areport from theUCLA Center for Health Policy Research.Ninety-six percent of people surveyed said that Parks After Dark provides a sense of belonging within their communities, and 94% said the program he...</description>
            <author>UCLA Newsroom: Health Sciences</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209844499</guid>        </item>
        <item>
            <title>Sleep Restriction Tied to Negative Cognitive Effects in Teens With Overweight, Obesity</title>
            <link>https://medworm.com/1209929221/sleep-restriction-tied-to-negative-cognitive-effects-in-teens-with-overweight-obesity/</link>
            <description>WEDNESDAY, May 22, 2024 -- Adolescents with overweight or obesity may be more vulnerable to negative cognitive effects following sleep restriction, according to a study published online May 20 in JAMA Neurology. 
Lindsay M. Stager, from University... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209929221</guid>        </item>
        <item>
            <title>Putting children as young as SIX on weight loss jabs like Ozempic could tackle spiraling under-40s diabetes crisis, top expert says</title>
            <link>https://medworm.com/1209822031/putting-children-as-young-as-six-on-weight-loss-jabs-like-ozempic-could-tackle-spiraling-under-40s-d/</link>
            <description>Giving obese children semaglutide could reduce their risk by 90 per cent. It comes after Diabetes UK revealed obesity has fuelled a 39 per cent spike in the condition among the under-40s. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209822031</guid>        </item>
        <item>
            <title>A case of accidental self-enucleation caused by obstructive sleep apnea - Baker N, Schenck CH, Golden E, Varghese R.</title>
            <link>https://medworm.com/1209747816/a-case-of-accidental-self-enucleation-caused-by-obstructive-sleep-apnea-baker-n-schenck-ch-golde/</link>
            <description>A novel form of injury associated with obstructive sleep apnea (OSA) that was comorbid with obesity hypoventilation syndrome, and severe daytime somnolence is reported in a 55 year-old woman, manifesting as severe ocular and extra-ocular muscle injuries su... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209747816</guid>        </item>
        <item>
            <title>Do Texts With Financial Incentives Aid Weight Loss in Men? Do Texts With Financial Incentives Aid Weight Loss in Men?</title>
            <link>https://medworm.com/1209804773/do-texts-with-financial-incentives-aid-weight-loss-in-men-do-texts-with-financial-incentives-aid-we/</link>
            <description>Text messages with financial incentives for men with obesity led to nearly two thirds losing 5% body weight over a year, and many men were from socially deprived groups.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209804773</guid>        </item>
        <item>
            <title>Experts demand obesity crackdown to cure sick note Britain after diabetes surge</title>
            <link>https://medworm.com/1209724939/experts-demand-obesity-crackdown-to-cure-sick-note-britain-after-diabetes-surge/</link>
            <description>Diagnoses of type 2 diabetes have surged among people under the age of 40, a Diabetes UK report reveals. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209724939</guid>        </item>
        <item>
            <title>Insufficient Sleep May Influence Cognition in Teens With Overweight and Obesity</title>
            <link>https://medworm.com/1209623205/insufficient-sleep-may-influence-cognition-in-teens-with-overweight-and-obesity/</link>
            <description>(MedPage Today) -- Adolescents with higher levels of adiposity appeared to be more susceptible to the negative cognitive effects of sleep restriction compared with those with lower levels of adiposity, a randomized crossover trial showed.
In a... (Source: MedPage Today Neurology)</description>
            <author>MedPage Today Neurology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209623205</guid>        </item>
        <item>
            <title>Semaglutide Has Lasting Benefit for Weight Loss</title>
            <link>https://medworm.com/1209634976/semaglutide-has-lasting-benefit-for-weight-loss/</link>
            <description>TUESDAY, May 21, 2024 -- Semaglutide has a long-term beneficial impact on weight, as well as cardiovascular benefits, regardless of weight loss, according to two studies presented at the annual meeting of the European Congress on Obesity, hosted by... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209634976</guid>        </item>
        <item>
            <title>Comparative analysis of postural stability and risk of falling and developing disability among overweight and obese women over 40 years - Gunay Ucurum S, Uzunlar H, Kirmizi M, Altas EU, Ozer Kaya D.</title>
            <link>https://medworm.com/1209551584/comparative-analysis-of-postural-stability-and-risk-of-falling-and-developing-disability-among-overw/</link>
            <description>BACKGROUND: Increased body mass index (BMI) adversely affects the mechanics of the musculoskeletal system. It is known that obese people have poorer postural stability and mobility-related outcomes compared to normal weight people, but there is limited res... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209551584</guid>        </item>
        <item>
            <title>The development, validation, and application of the campus walk score measurement system - Zhang Z, Wang H, Fisher T.</title>
            <link>https://medworm.com/1209551154/the-development-validation-and-application-of-the-campus-walk-score-measurement-system-zhang-z-/</link>
            <description>This study aimed to formulate an optimized campus Walk Score (WS) measurement system that... (Source: SafetyLit)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209551154</guid>        </item>
        <item>
            <title>Scientists Are Studying Weight-Loss Drugs for Way More Than Weight Loss</title>
            <link>https://medworm.com/1209627341/scientists-are-studying-weight-loss-drugs-for-way-more-than-weight-loss/</link>
            <description>The new weight-loss drugs Wegovy and Zepbound are in high demand, and the clamoring will only increase in coming years, experts predict. That&amp;#8217;s because drugs like these, which rely at least in part on the appetite-regulating hormone GLP-1, are being investigated not just for weight loss and diabetes, but also for a wide range of other conditions.



&amp;#8220;Weight loss is only part of it,&amp;#8221; says Dr. Ian Neeland, chair of the American Heart Association&amp;rsquo;s obesity science committee and an associate professor of medicine at Case Western Reserve University. 
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Here&amp;rsquo;s the latest (and still-growing) list.



Heart disease



In March, the U.S. Food and Drug Administration (FDA) allowed doctors to prescribe Wegovy (semaglutide) t...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209627341</guid>        </item>
        <item>
            <title>New Analysis Finds Endoscopic Sleeve Gastroplasty More Cost Effective Than Lifestyle Modification for Weight Loss</title>
            <link>https://medworm.com/1209535857/new-analysis-finds-endoscopic-sleeve-gastroplasty-more-cost-effective-than-lifestyle-modification-fo/</link>
            <description>A new study reveals that endoscopic sleeve gastroplasty (ESG) is significantly more cost-effective than lifestyle modifications for treating obesity. This real-world study underscores ESG's potential as a cost-efficient obesity treatment and can assist in helping advocate for broader... (Source: PRWeb: Medical Pharmaceuticals)</description>
            <author>PRWeb:  Medical  Pharmaceuticals</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209535857</guid>        </item>
        <item>
            <title>Social Media a'Powerful' Way to Talk to Teens About Obesity Social Media a'Powerful' Way to Talk to Teens About Obesity</title>
            <link>https://medworm.com/1209527407/social-media-a-powerful-way-to-talk-to-teens-about-obesity-social-media-a-powerful-way-to-/</link>
            <description>A short semaglutide video on TikTok drew close to 1 million views.Medscape Medical News (Source: Medscape Medical News Headlines)</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209527407</guid>        </item>
        <item>
            <title>Genetic Test Can Predict Response to Semaglutide Genetic Test Can Predict Response to Semaglutide</title>
            <link>https://medworm.com/1209509770/genetic-test-can-predict-response-to-semaglutide-genetic-test-can-predict-response-to-semaglutide/</link>
            <description>With an assist from machine learning, investigators find a genetic test that can identify obesity phenotypes and predict who will benefit most from semaglutide for weight loss.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209509770</guid>        </item>
        <item>
            <title>The global ‘spermpocalypse’ proves infertility is no longer just a women’s problem, says male fertility CEO</title>
            <link>https://medworm.com/1209428911/the-global-spermpocalypse-proves-infertility-is-no-longer-just-a-womens-problem-says-male-/</link>
            <description>Across the globe, male sperm count is on the decline—a decades-long drop that has been alternately blamed on pesticides, heavy metals, obesity, and potentially microplastics. More worrying, the decline seems to be speeding up—by the calculations of one male fertility founder, sperm counts have…#permpocalypse #khaledkteily #danapoint #grandviewresearch #brianlevine #posterityhealth #pamelapure #neelshah #mavenclinic #kteily (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209428911</guid>        </item>
        <item>
            <title>African Tree Fruit Beats Dangerous New “ Diet ”  Drugs</title>
            <link>https://medworm.com/1209305630/african-tree-fruit-beats-dangerous-new-diet-drugs/</link>
            <description>There’s a hot new trend in the world of quick-fix weight loss solutions&amp;#8230; I’m sure you’ve heard about it on the news.
I’m talking about the diabetes drug Ozempic.
Right now, demand for this drug is so high that even patients who are prescribed it to control their blood sugar can’t get their hands on it. (Of course, I don’t recommend using any Big Pharma drug to control your blood sugar.)




Healers on almost every continent I’ve traveled to have told me about the health benefits of the moringa tree – including its incredible weight loss properties.






But it’s easy to understand why women are turning to medications like Ozempic in their quest to fight obesity&amp;#8230;
You see, when you do a quick internet search for “what causes obesity,” the first place Googl...</description>
            <author>Al Sears, MD Natural Remedies</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209305630</guid>        </item>
        <item>
            <title>Break Free From Addictive Junk Food</title>
            <link>https://medworm.com/1209305632/break-free-from-addictive-junk-food/</link>
            <description>I’m sure you know how hard it can be to resist certain insulin-spiking foods that score high on the glycemic index – like French fries, potato chips, pasta, and bagels.
But why?
The answer has nothing to do with weak willpower and it certainly has nothing to do with the latest nonsense from mainstream medicine about having a genetic mutation that makes you crave sweet foods.
The real reason your brain craves junk food is far more disturbing&amp;#8230;
In a breakthrough study, researchers at Yale and the University of Cologne reveal that your brain has been trained to crave and consume processed foods.
If you don’t do something about it, you won’t just gain weight; you’ll leave yourself vulnerable to all kinds of chronic conditions, like diabetes, heart disease, obesity, and cancer.
T...</description>
            <author>Al Sears, MD Natural Remedies</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209305632</guid>        </item>
        <item>
            <title>Pediatricians Reverse Decades-Old Advice Against HIV-Positive Mothers Breastfeeding</title>
            <link>https://medworm.com/1209331851/pediatricians-reverse-decades-old-advice-against-hiv-positive-mothers-breastfeeding/</link>
            <description>People with HIV can breastfeed their babies, as long as they are taking medications that effectively suppress the virus that causes AIDS, a top U.S. pediatricians&amp;rsquo; group said Monday in a sharp policy change.



The new report from the American Academy of Pediatrics reverses recommendations it had in place since the start of the HIV epidemic in the 1980s.



It recognizes that routinely prescribed drugs can reduce the risk of transmitting HIV via breast milk to less than 1%, said Dr. Lisa Abuogi, a pediatric HIV expert at the University of Colorado and lead author of the report.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




&amp;ldquo;The medications are so good now and the benefits for mom and baby are so important that we are at a point where it is important to engage in shared decis...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209331851</guid>        </item>
        <item>
            <title>Are YOU living in a fat hotspot? Our interactive map reveals areas where four in ten adults are obese... and a staggering eight in ten are overweight</title>
            <link>https://medworm.com/1209330253/are-you-living-in-a-fat-hotspot-our-interactive-map-reveals-areas-where-four-in-ten-adults-are-obes/</link>
            <description>Figures show four in ten residents in Wigan and Swale are now obese. For comparison, just a tenth of people in Kensington and Chelsea fall into the same category. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209330253</guid>        </item>
        <item>
            <title>Breast density, obesity tied to interval cancers in Korean women</title>
            <link>https://medworm.com/1209343490/breast-density-obesity-tied-to-interval-cancers-in-korean-women/</link>
            <description>Breast density, obesity, and hormone replacement therapy use are tied to interval breast cancer in Korean women when compared with screen-detected breast cancer, according to research published May 20 in JAMA Network Open. A team led by Boyoung Park, MD, PhD, from Hanyang University in Seoul, South Korea also found that overall mortality from interval breast cancer is comparable with that of screen-detected breast cancer in these women. “These findings also suggest that higher supplemental breast ultrasound use among Korean women, especially those with dense breasts, could be attributed to a lower incidence of interval breast cancer among women with dense breasts compared with women with screen-detected breast cancer, due to greater detection,” the Park team wrote. In South Korea, b...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>AuntMinnie.com Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209343490</guid>        </item>
        <item>
            <title>Demographic, socioeconomic and life-course risk factors for internalized weight stigma in adulthood: evidence from an English birth cohort study - Hughes AM, Flint SW, Clare K, Kousoulis AA, Rothwell ER, Bould H, Howe LD.</title>
            <link>https://medworm.com/1209255601/demographic-socioeconomic-and-life-course-risk-factors-for-internalized-weight-stigma-in-adulthood/</link>
            <description>BACKGROUND: Obesity is highly stigmatized, with negative obesity-related stereotypes widespread across society. Internalized weight stigma (IWS) is linked to negative outcomes including poor mental health and disordered eating. Previous evidence examining ... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209255601</guid>        </item>
        <item>
            <title>A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs</title>
            <link>https://medworm.com/1209331853/a-new-test-predicts-who-will-benefit-most-from-weight-loss-drugs/</link>
            <description>As popular as the new group of weight-loss drugs like Wegovy and Zepbound are, not everyone responds to them in the same way.



In a new presentation at the Digestive Disease Week conference in Washington, Mayo Clinic associate professor of medicine Dr. Andres Acosta reported that a genetic test he developed can identify which people are most likely to respond to semaglutide (Wegovy) and which are not.



The test, called MyPhenome, from a company Acosta co-founded called Phenomix, relies on a combination of genetic and other factors to categorize people into different types of weight gain. Acosta identified about two dozen genes linked to obesity, and more than 6,000 variants of these genes, to sort people who struggle with weight gain into four categories:
[time-brightcove not-tgx=&amp;#822...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209331853</guid>        </item>
        <item>
            <title>Interventions to prevent obesity in children aged 5 to 18 years old</title>
            <link>https://medworm.com/1209419291/interventions-to-prevent-obesity-in-children-aged-5-to-18-years-old/</link>
            <description>Monday, May 20, 2024 (Source: Cochrane News and Events)</description>
            <author>Cochrane News and Events</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1209419291</guid>        </item>
        <item>
            <title>Street calls of the week: Upgrades for Intel and Robinhood; downgrade for SunPower By</title>
            <link>https://medworm.com/1208936978/street-calls-of-the-week-upgrades-for-intel-and-robinhood-downgrade-for-sunpower-by/</link>
            <description>Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Intel, Robinhood (NASDAQ: ) and Boston Beer (NYSE: ); downgrade for SunPower (NASDAQ: ). InvestingPro subscribers always get first dibs on market-moving rating changes. What…#intel #bostonbeer #sunpower #investingpro #pipersandler #mastercard #overweight #tam #jefferies #boston (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208936978</guid>        </item>
        <item>
            <title>Pharma’s next big obesity win will be a challenge</title>
            <link>https://medworm.com/1208945843/pharmas-next-big-obesity-win-will-be-a-challenge/</link>
            <description>The sector’s holy grail of an effective, easily manufactured weight loss pill does not look imminent (Source: FT.com - Drugs and Healthcare)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208945843</guid>        </item>
        <item>
            <title>Britain's 'fattest town' where the majority of people are overweight named</title>
            <link>https://medworm.com/1208743344/britains-fattest-town-where-the-majority-of-people-are-overweight-named/</link>
            <description>It has played host to the World Pie Eating Championships, but Wigan's obesity crisis is laid bare with almost two in five locals considered obese. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208743344</guid>        </item>
        <item>
            <title>This is the best time of day to exercise for people living with obesity, new study shows</title>
            <link>https://medworm.com/1208644352/this-is-the-best-time-of-day-to-exercise-for-people-living-with-obesity-new-study-shows/</link>
            <description>Depending on your body composition and overall health, it turns out there is a best time of day to exercise. People living with obesity reap the greatest health benefits from being physically active in the evening, according to a new Australian study. Researchers at the University of Sydney’s…#australian #universityofsydneys #charlesperkinscentre #angelosabag #phd #biobank #mvpa #matthewahmadi #insulin #lorettadipietro (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208644352</guid>        </item>
        <item>
            <title>Slight Body Mass Gains in Middle Age May Cut Later Fracture Risk</title>
            <link>https://medworm.com/1208555237/slight-body-mass-gains-in-middle-age-may-cut-later-fracture-risk/</link>
            <description>FRIDAY, May 17, 2024 -- People whose body mass index (BMI) slightly increases from normal weight to low-level overweight during 30 years of middle adulthood have a lower risk for fracture in later life, according to a study published online April 8... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208555237</guid>        </item>
        <item>
            <title>Wegovy should be treating more than just obesity</title>
            <link>https://medworm.com/1208546059/wegovy-should-be-treating-more-than-just-obesity/</link>
            <description>A new analysis highlights the significant cardiovascular benefits of Novo Nordisk's obesity drug Wegovy, showing improvements regardless of weight loss amount. This challenges perceptions of GLP-1 drugs, suggesting they could be viewed more as heart or metabolic medications. Improved access and understanding are crucial, as these drugs could impact various chronic conditions like kidney disease. Acknowledging these connections could lead to more effective treatment approaches and better outcomes. (Source: The Economic Times)</description>
            <author>The Economic Times</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208546059</guid>        </item>
        <item>
            <title>Why Insulin Resistance Is Higher in Men With Obesity? Why Insulin Resistance Is Higher in Men With Obesity?</title>
            <link>https://medworm.com/1208431202/why-insulin-resistance-is-higher-in-men-with-obesity-why-insulin-resistance-is-higher-in-men-with-o/</link>
            <description>In comparing women and men with obesity, researchers proposed that the latter are more insulin resistant due to less efficient inhibition of fat cell lipolysis.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208431202</guid>        </item>
        <item>
            <title>Keeping Muscle While Losing Fat Is Next Goal for Obesity Drugs</title>
            <link>https://medworm.com/1208349869/keeping-muscle-while-losing-fat-is-next-goal-for-obesity-drugs/</link>
            <description>(Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208349869</guid>        </item>
        <item>
            <title>Global obesity deaths rise by 50 percent since 2000, major report shows - but how does the US compare to other nations?</title>
            <link>https://medworm.com/1208349626/global-obesity-deaths-rise-by-50-percent-since-2000-major-report-shows-but-how-does-the-us-compar/</link>
            <description>In the year 2000, high BMI was the 11th leading risk factor in the world for shortening a person's life. By 2021, it had jumped to the sixth spot. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208349626</guid>        </item>
        <item>
            <title>Obesity and High Blood Sugar Play Ever Growing Role in Ill-health, Study Shows Obesity and High Blood Sugar Play Ever Growing Role in Ill-health, Study Shows</title>
            <link>https://medworm.com/1208431206/obesity-and-high-blood-sugar-play-ever-growing-role-in-ill-health-study-shows-obesity-and-high-bloo/</link>
            <description>Obesity, high blood sugar and high blood pressure among other metabolic issues now lead to almost 50% more years of healthy life lost to either disease or premature death...Reuters Health Information (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208431206</guid>        </item>
        <item>
            <title>Is Body Fat a Better Measure of Obesity in Midlife Than BMI? Is Body Fat a Better Measure of Obesity in Midlife Than BMI?</title>
            <link>https://medworm.com/1208225727/is-body-fat-a-better-measure-of-obesity-in-midlife-than-bmi-is-body-fat-a-better-measure-of-obesity/</link>
            <description>The conventional BMI cutoff for obesity may be better replaced with adiposity measures that accommodate changes in the body fat-to-muscle ratio that changes in the midlife years.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208225727</guid>        </item>
        <item>
            <title>Obesity Mystery Solved: The Reversible Cause You Never Knew</title>
            <link>https://medworm.com/1208225706/obesity-mystery-solved-the-reversible-cause-you-never-knew/</link>
            <description>(MedPage Today) -- 

Internal medicine and rheumatology specialist Siobhan Deshauer, MD, solves the mystery case of Leslie, a woman who experienced unexplained weight gain and a host of other symptoms.
Following is a partial transcript of the... (Source: MedPage Today Endocrinology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Endocrinology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208225706</guid>        </item>
        <item>
            <title>Roche's experimental obesity drug shows promising early stage results</title>
            <link>https://medworm.com/1208248567/roche-s-experimental-obesity-drug-shows-promising-early-stage-results/</link>
            <description>Swiss drug company Roche on Thursday said its experimental obesity treatment helped people lose a significant amount of weight in an early-stage trial. (Source: Health News - UPI.com)</description>
            <author>Health News - UPI.com</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208248567</guid>        </item>
        <item>
            <title>Scientists discover a NEW weight loss shot that could burn twice as much fat as Ozempic</title>
            <link>https://medworm.com/1208247344/scientists-discover-a-new-weight-loss-shot-that-could-burn-twice-as-much-fat-as-ozempic/</link>
            <description>A new weight loss drug could ramp up fat loss, , early trial data has shown. Obese patients lost roughly 19 percent of their body weight, compared to 10 percent on Ozempic. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208247344</guid>        </item>
        <item>
            <title>Childhood Weight Status May Stratify Mortality Risk in Adults With Obesity</title>
            <link>https://medworm.com/1208256440/childhood-weight-status-may-stratify-mortality-risk-in-adults-with-obesity/</link>
            <description>THURSDAY, May 16, 2024 -- In adults with obesity, childhood weight status may stratify mortality risk, according to a study presented at the annual meeting of the European Congress on Obesity, hosted by the European Association for the Study of... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208256440</guid>        </item>
        <item>
            <title>For Women With Obesity, Risk for Breast Cancer Drops After Bariatric Surgery</title>
            <link>https://medworm.com/1208256442/for-women-with-obesity-risk-for-breast-cancer-drops-after-bariatric-surgery/</link>
            <description>THURSDAY, May 16, 2024 -- For women with obesity, the risk for breast cancer is reduced after bariatric surgery, according to a study published online May 15 in JAMA Surgery. 
Felipe M. Kristensson, M.D., from the Sahlgrenska Academy at the... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208256442</guid>        </item>
        <item>
            <title>World Hypertension Day on 17 May 2024: Know your blood pressure, and control it!</title>
            <link>https://medworm.com/1208188044/world-hypertension-day-on-17-may-2024-know-your-blood-pressure-and-control-it/</link>
            <description>16 May 2024 – Hypertension is a silent yet deadly public health problem. Today, on World Hypertension Day 2024, we remind all adults to get your blood pressure measured accurately and control it to live longer. Early detection and careful management of hypertension are vital.
Hypertension is a leading risk factor for premature death and disability – in the WHO Eastern Mediterranean Region especially. Untreated hypertension can lead to serious medical complications such as stroke, heart attack, heart failure, kidney damage, and other debilitating health issues.
In 2019, hypertension was estimated to affect 38% of adults aged 30–79 years in the Region – more than 104 million people. Shockingly, more than half of them (51%) are unaware of their status, and over 60% of the total are ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>WHO EMRO News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208188044</guid>        </item>
        <item>
            <title>Roche ramps up obesity-drug competition with early-stage trial results</title>
            <link>https://medworm.com/1208144355/roche-ramps-up-obesity-drug-competition-with-early-stage-trial-results/</link>
            <description>The race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche Holding released early-stage trial results for an experimental obesity treatment.#rocheholding (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208144355</guid>        </item>
        <item>
            <title>Netflix's NFL Games Through 2026 Set To Drive Explosive Subscriber, Ad Revenue Growth, Says Analyst</title>
            <link>https://medworm.com/1208144435/netflix-s-nfl-games-through-2026-set-to-drive-explosive-subscriber-ad-revenue-growth-says-analys/</link>
            <description>Netflix Inc. NFLX is gearing up for a game-changing move that could significantly boost its subscriber base and ad revenue: the acquisition of rights to NFL games on Christmas Day from 2024 to 2026. This bold step, coupled with the company’s successful ad tier growth and upcoming ad tech…#netflixinc #nflx #nfl #netflix #jpmorgan #douganmuth #overweight #tradedesk #magnite #xandr (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208144435</guid>        </item>
        <item>
            <title>Roche says obesity drug results ‘encouraging’ as competition heats up</title>
            <link>https://medworm.com/1208153153/roche-says-obesity-drug-results-encouraging-as-competition-heats-up/</link>
            <description>Weekly injection delivered 18.8% weight loss over 24 weeks (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208153153</guid>        </item>
        <item>
            <title>[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase Ib results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity</title>
            <link>https://medworm.com/1208052709/ad-hoc-announcement-pursuant-to-art-53-lr-roche-reports-positive-phase-ib-results-for-its-dual-gl/</link>
            <description>Over 24 weeks, a once-weekly subcutaneous injection of CT-388 achieved a clinically meaningful and statistically significant mean placebo-adjusted weight loss of 18.8% (p&amp;lt; 0.001)At week 24, 100% of CT-388 treated participants achieved&amp;gt;5% weight loss, 70% achieved&amp;gt;15% and 45% achieved&amp;gt;20% weight lossIn a subgroup with pre-diabetes at baseline, CT-388 treatment normalised glycemia in all patients, indicating its strong impact on glucose homeostasisNo new or unexpected safety signals were detected. Overall, CT-388 demonstrated a safety and tolerability profile consistent with its drug classBasel, 16 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase I clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the trea...</description>
            <author>Roche Investor Update</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208052709</guid>        </item>
        <item>
            <title>Widening Disparities Seen in Youth Obesity</title>
            <link>https://medworm.com/1208052594/widening-disparities-seen-in-youth-obesity/</link>
            <description>WEDNESDAY, May 15, 2024 -- In the 2019 to 2020 school year, 20.9 percent of New York City elementary and middle school students had obesity, and 6.4 percent had severe obesity, according to a study published online May 15 in&amp;nbsp;PLOS ONE.Kira L.... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208052594</guid>        </item>
        <item>
            <title>Smoking Tied to Poor Eating Habits</title>
            <link>https://medworm.com/1208052596/smoking-tied-to-poor-eating-habits/</link>
            <description>WEDNESDAY, May 15, 2024 -- Smokers tend to eat less and have less healthy eating habits than nonsmokers, according to a study presented at the annual meeting of the European Congress on Obesity, hosted by the European Association for the Study of... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1208052596</guid>        </item>
        <item>
            <title>South Park: The End of Obesity Teaser Trailer</title>
            <link>https://medworm.com/1207942858/south-park-the-end-of-obesity-teaser-trailer/</link>
            <description>Check out the new South Park: The End of Obesity Teaser Trailer! ► Learn more: https://www.rottentomatoes.com/tv/south_park/?cmp=RTTV_YouTube_Desc Subscribe to the channel and click the bell icon to be notified of all the latest TV &amp; streaming series: http://bit.ly/2qTF6ZY ► Shop Rotten Tomatoes:…#southpark #learn #treyparker #mattstone #monamarshallnetwork #rottentomatoestv (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207942858</guid>        </item>
        <item>
            <title>Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss</title>
            <link>https://medworm.com/1207921083/smartphone-based-lifestyle-interventions-result-in-modest-sustained-weight-loss/</link>
            <description>(MedPage Today) -- Smartphone-based behavioral interventions for weight loss were more effective when they involved financial incentives or one-on-one coaching calls, two randomized trials showed.
In one trial, middle-age men with obesity who... (Source: MedPage Today Endocrinology)</description>
            <author>MedPage Today Endocrinology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207921083</guid>        </item>
        <item>
            <title>Obesity, Low Body Mass Linked to Mental Health Concerns in Adolescents</title>
            <link>https://medworm.com/1207898805/obesity-low-body-mass-linked-to-mental-health-concerns-in-adolescents/</link>
            <description>(MedPage Today) -- Adolescents with low body mass and overweight or obesity had increased psychosomatic symptoms compared to peers with healthy weight, according to multi-country, cross-sectional study.
An analysis of more than 1 million adolescents... (Source: MedPage Today Psychiatry)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Psychiatry</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207898805</guid>        </item>
        <item>
            <title>Could YOU be 'fat' and not realise it? Experts propose shake-up of BMI rules that would mean the average person over 40 would be reclassified as obese</title>
            <link>https://medworm.com/1207942612/could-you-be-fat-and-not-realise-it-experts-propose-shake-up-of-bmi-rules-that-would-mean-the-ave/</link>
            <description>Millions more Brits could be labelled obese in a proposed major shake-up of body-mass-index classification (BMI) system and their not alone, with stars also caught up in the obesity shake-up. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207942612</guid>        </item>
        <item>
            <title>Text Messages + Financial Incentives Boost Weight Loss at 12 Months</title>
            <link>https://medworm.com/1207951753/text-messages-financial-incentives-boost-weight-loss-at-12-months/</link>
            <description>WEDNESDAY, May 15, 2024 -- Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group, according to a study published online May 14 in the&amp;nbsp;Journal of the... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207951753</guid>        </item>
        <item>
            <title>GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription</title>
            <link>https://medworm.com/1207951754/glp-1-receptor-agonist-use-increases-likelihood-of-antidepressant-prescription/</link>
            <description>WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in&amp;nbsp;Diabetes, Obesity, and... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207951754</guid>        </item>
        <item>
            <title>No Added Weight Loss Benefits Switching Healthy Diets? No Added Weight Loss Benefits Switching Healthy Diets?</title>
            <link>https://medworm.com/1207921106/no-added-weight-loss-benefits-switching-healthy-diets-no-added-weight-loss-benefits-switching-healt/</link>
            <description>Switching from one healthy weight loss diet to another did not overcome the typical weight loss plateau at 6 months in individuals with overweight and obesity.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207921106</guid>        </item>
        <item>
            <title>Tackling Lean Mass Loss When Weight Loss is Successful Tackling Lean Mass Loss When Weight Loss is Successful</title>
            <link>https://medworm.com/1207921107/tackling-lean-mass-loss-when-weight-loss-is-successful-tackling-lean-mass-loss-when-weight-loss-is-s/</link>
            <description>The loss of lean mass has become a hot topic with new anti-obesity drugs, but such changes can occur with most successful weight loss interventions — without meaningful countermeasures.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207921107</guid>        </item>
        <item>
            <title>Setmelanotide Shows Promise in Hypothalamic Obesity Setmelanotide Shows Promise in Hypothalamic Obesity</title>
            <link>https://medworm.com/1207819944/setmelanotide-shows-promise-in-hypothalamic-obesity-setmelanotide-shows-promise-in-hypothalamic-obes/</link>
            <description>Treatment with setmelanotide, a melanocortin-4 receptor agonist, led to a significant reduction in BMI in a difficult-to-treat population of patients with hypothalamic obesity.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207819944</guid>        </item>
        <item>
            <title>One Key to Weight Loss for Men: Competing for Cash</title>
            <link>https://medworm.com/1207939369/one-key-to-weight-loss-for-men-competing-for-cash/</link>
            <description>WEDNESDAY, May 15, 2024 -- A competitive game with a potential cash reward appeared to help overweight British men lose weight, researchers report. 
The incentive was winning the &quot; Game of Stones &quot; -- a stone is a British measurement of body weight... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207939369</guid>        </item>
        <item>
            <title>Cash incentives may help men lose weight, research finds</title>
            <link>https://medworm.com/1207879610/cash-incentives-may-help-men-lose-weight-research-finds/</link>
            <description>Men with obesity offered incentives and sent healthy-eating tips in Game of Stones trial found to have lost most weightFinancial incentives of up to £400 alongside text messages could encourage men living with obesity to lose weight, research has found.The research, known as Game of Stones and presented at the European Congress of Obesity, involved a year-long trial involving 585 men living with obesity from Belfast, Bristol and Glasgow.Continue reading... (Source: Guardian Unlimited Science)</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207879610</guid>        </item>
        <item>
            <title>Wednesday briefing: The study that says semaglutide can do much more than help you lose weight</title>
            <link>https://medworm.com/1207879611/wednesday-briefing-the-study-that-says-semaglutide-can-do-much-more-than-help-you-lose-weight/</link>
            <description>In today ’s newsletter: A new study suggests semaglutides reduce not just obesity but risks to your heart too. What will that mean for their availability on the NHS?•Sign up here for our daily newsletter, First EditionGood morning. If you hear brand names like Ozempic and Wegovy and think of suddenly gaunt A-listers posing on the red carpet, it is surely now time to think again. There has already been substantial evidence that as well as in their initial role as a diabetes treatment, semaglutides – the kind of drug in question – can have a real impact on obesity for people for whom nothing else works. Now a new study has found that they don’t just help those people lose weight –they have a major effect on their heart health, regardless of how much weight they lose.Obesity affec...</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207879611</guid>        </item>
        <item>
            <title>Millions more middle-aged are obese, study suggests</title>
            <link>https://medworm.com/1207741486/millions-more-middle-aged-are-obese-study-suggests/</link>
            <description>Using a new, lower BMI cut-off for obesity would give a truer picture of who is affected, researchers say. (Source: BBC News | Health | UK Edition)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>BBC News | Health | UK Edition</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207741486</guid>        </item>
        <item>
            <title>Why are elite athletes prone to abnormal heart rhythms?</title>
            <link>https://medworm.com/1207676687/why-are-elite-athletes-prone-to-abnormal-heart-rhythms/</link>
            <description>On 1 July 2023, as Tour de France riders pedaled out of Bilbao, Spain, toward the French Pyrenees mountains, sports cardiologist Andre La Gerche tuned in from Melbourne, Australia. “It’s exciting watching the screen and knowing the engines”—the hearts powering the cyclists forward, says La Gerche, who works at the St. Vincent’s Institute of Medical Research and the Victor Chang Cardiac Research Institute. Five of the cyclists who won daily stages early in the race are also participants in an ambitious study, led by La Gerche, of the effects of endurance exercise on the heart. These include powerful protection against heart disease—but also the potential, in some endurance athletes, to bring on a troublesome arrhythmia called atrial fibrillation (AF).
 
 
 Most AF patients are o...</description>
            <author>ScienceNOW</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207676687</guid>        </item>
        <item>
            <title>Doctors declare Ozempic overrated as first long-term trial shows patients keep just 10% of their bodyweight off after four YEARS on drug</title>
            <link>https://medworm.com/1207741128/doctors-declare-ozempic-overrated-as-first-long-term-trial-shows-patients-keep-just-10-of-their-bod/</link>
            <description>A new study found that people can keep ten percent of their original body weight off by using Wegovy. Experts say this might be enough to fight off severe cases of obesity. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207741128</guid>        </item>
        <item>
            <title>Semaglutide CV Benefits Irrespective of Weight Lost? Semaglutide CV Benefits Irrespective of Weight Lost?</title>
            <link>https://medworm.com/1207608549/semaglutide-cv-benefits-irrespective-of-weight-lost-semaglutide-cv-benefits-irrespective-of-weight-/</link>
            <description>Semaglutide remains effective for weight loss at 4 years in people with preexisting cardiovascular disease and overweight/obesity but without T2D and provides CV benefits regardless of weight.Medscape Medical News (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207608549</guid>        </item>
        <item>
            <title>Britain's looming 'over-zempic' crisis? Experts warn against overmedicalising obesity amid calls for slimming jabs to be doled out like statins to slash heart attacks and strokes</title>
            <link>https://medworm.com/1207640351/britains-looming-over-zempic-crisis-experts-warn-against-overmedicalising-obesity-amid-calls-for/</link>
            <description>It comes as research finds weekly shots of semaglutide, sold as Ozempic and Wegovy, cut the risk of heart attacks or death by a fifth even among patients who didn't lose weight. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207640351</guid>        </item>
        <item>
            <title>Can weight-loss drugs such as Ozempic also treat addiction and dementia?</title>
            <link>https://medworm.com/1207678479/can-weight-loss-drugs-such-as-ozempic-also-treat-addiction-and-dementia/</link>
            <description>Studies show active ingredient semaglutide can reduce the risk of heart attack, improve fertility and help treat diabetesIt is a drug that has dominated headlines, first as a medication for type 2 diabetes, then as a weight-loss aid. Now it seems semaglutide – often called by its brand names Ozempic or Wegovy – could bring benefits in myriad areas of healthcare, from addiction to dementia.Continue reading... (Source: Guardian Unlimited Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207678479</guid>        </item>
        <item>
            <title>Do Obesity Drug Clinical Trials Reflect the Real World? Do Obesity Drug Clinical Trials Reflect the Real World?</title>
            <link>https://medworm.com/1207819953/do-obesity-drug-clinical-trials-reflect-the-real-world-do-obesity-drug-clinical-trials-reflect-the-/</link>
            <description>Randomised controlled trial participants are more White, female, and leaner than the real-world populations with obesity.Medscape UK (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207819953</guid>        </item>
        <item>
            <title>More Studies Support Wegovy's Long-Term Weight-Loss Benefits</title>
            <link>https://medworm.com/1207637106/more-studies-support-wegovy-s-long-term-weight-loss-benefits/</link>
            <description>TUESDAY, May 14, 2024 -- Semaglutide -- the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy -- can produce long-term weight and heart health benefits, a pair of new studies show. 
Researchers found that overweight and obese... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207637106</guid>        </item>
        <item>
            <title>Does Childhood Weight Alter Health Risks in Adults? Does Childhood Weight Alter Health Risks in Adults?</title>
            <link>https://medworm.com/1207539564/does-childhood-weight-alter-health-risks-in-adults-does-childhood-weight-alter-health-risks-in-adul/</link>
            <description>Self-perceived weight as a child may influence risks for all-cause mortality and incident cardiovascular disease in adults who are overweight or obese.Medscape Medical News (Source: Medscape Medical News Headlines)</description>
            <author>Medscape Medical News Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207539564</guid>        </item>
        <item>
            <title>Smoking During Pregnancy Could Raise Baby's Odds for Obesity Later</title>
            <link>https://medworm.com/1207637112/smoking-during-pregnancy-could-raise-baby-s-odds-for-obesity-later/</link>
            <description>TUESDAY, May 14, 2024 -- Women who smoke during pregnancy run a higher risk of their kids becoming overweight or obese, and researchers now think they know one reason why. 
Children born of moms who smoked while expecting tend to have gut bacteria... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207637112</guid>        </item>
        <item>
            <title>Weight loss drug could reduce heart attack risk by 20%, study finds</title>
            <link>https://medworm.com/1207475273/weight-loss-drug-could-reduce-heart-attack-risk-by-20-study-finds/</link>
            <description>Researchers say semaglutide, the active ingredient in Wegovy and Ozempic, could be biggest medical breakthrough since statinsA weight loss injection could reduce the risk of heart attacks and benefit the cardiovascular health of millions of adults across the UK, in what could be the largest medical breakthrough since statins, according to a study.It found that participants taking the medication semaglutide, the active ingredient in brands including Wegovy and Ozempic, had a 20% lower risk of heart attack, stroke, or death due to cardiovascular disease.Continue reading... (Source: Guardian Unlimited Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207475273</guid>        </item>
        <item>
            <title>British firms should measure employees' waists like they do in Japan to keep staff slim, obesity campaigner says</title>
            <link>https://medworm.com/1207437437/british-firms-should-measure-employees-waists-like-they-do-in-japan-to-keep-staff-slim-obesity-cam/</link>
            <description>Calls for the Japanese style measure to be introduced in the UK comes after a study suggested time off work for obesity-related illness is seriously hampering British economic growth. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207437437</guid>        </item>
        <item>
            <title>Childhood Weight Recall Key to Predicting Obesity Mortality</title>
            <link>https://medworm.com/1207395774/childhood-weight-recall-key-to-predicting-obesity-mortality/</link>
            <description>Adulthood overweight and obesity may confer greater risks for all-cause mortality and incident CVD among individuals who perceive themselves to have been thinner or plumper than the average child (Source: Disabled World)</description>
            <author>Disabled World</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207395774</guid>        </item>
        <item>
            <title>Metabolic Syndrome, Obesity Independently Linked to Breast Cancer</title>
            <link>https://medworm.com/1207345670/metabolic-syndrome-obesity-independently-linked-to-breast-cancer/</link>
            <description>MONDAY, May 13, 2024 -- Metabolic syndrome (MetS) and obesity have independent and distinct associations with breast cancer subtypes and mortality, according to a study published online May 13 in Cancer.Rowan T. Chlebowski, M.D., Ph.D., from The... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207345670</guid>        </item>
        <item>
            <title>Obese Brits put the whole country in the slow lane: Fat staff are twice as likely to take time off sick and are 'seriously hampering economic growth', report finds</title>
            <link>https://medworm.com/1207235892/obese-brits-put-the-whole-country-in-the-slow-lane-fat-staff-are-twice-as-likely-to-take-time-off-s/</link>
            <description>Those who are overweight - nearly four in ten Brits - are 22 per cent more likely to have taken off at least seven days in a year for illness, according a study co-authored by Dr Thomas Czypionka (pictured). (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207235892</guid>        </item>
        <item>
            <title>Biocon inks supply, distribution pact with Medix for chronic weight management drug in Mexico</title>
            <link>https://medworm.com/1207245281/biocon-inks-supply-distribution-pact-with-medix-for-chronic-weight-management-drug-in-mexico/</link>
            <description>Biocon partners with Medix to distribute Liraglutide for chronic weight management in Mexico, offering affordable obesity treatment options. The collaboration aims to improve patient access and quality of life in a country with high obesity rates. (Source: The Economic Times Healthcare and Biotech News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207245281</guid>        </item>
        <item>
            <title>Time-off work for obesity-related illness is 'seriously hampering economic growth' as report reveals 60 per cent are 'taking sick leave due to rising obesity'</title>
            <link>https://medworm.com/1207134562/time-off-work-for-obesity-related-illness-is-seriously-hampering-economic-growth-as-report-reveals/</link>
            <description>Those who are overweight - nearly four in ten Brits - are 22 per cent more likely to have taken off at least seven days in a year for illness, according to a data analysis. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207134562</guid>        </item>
        <item>
            <title>Children who use phones or watch television at mealtimes are significantly more likely to be overweight, study finds</title>
            <link>https://medworm.com/1207134563/children-who-use-phones-or-watch-television-at-mealtimes-are-significantly-more-likely-to-be-overwei/</link>
            <description>Children who use phones or watch television at mealtimes are much more likely to be overweight, a study has found. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1207134563</guid>        </item>
        <item>
            <title>Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says</title>
            <link>https://medworm.com/1206931794/weaning-off-ozempic-slowly-instead-of-quitting-abruptly-can-help-prevent-patients-from-regaining-wei/</link>
            <description>Patients could wean themselves off blockbuster obesity drugs such as Ozempic or Wegovy without piling the pounds back on, according to a scientific study. Data presented at the European Congress on Obesity in Venice, Italy on Sunday provides some of the first evidence that it could be possible to…#wean #venice #ozempic #elilillys #danish #wegovy #embla #henrikgudbergsen #goldmansachs (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206931794</guid>        </item>
        <item>
            <title>Supported Exercise Intervention Helps Black Women With Obesity Shed Weight</title>
            <link>https://medworm.com/1206798148/supported-exercise-intervention-helps-black-women-with-obesity-shed-weight/</link>
            <description>(MedPage Today) -- NEW ORLEANS -- A &quot;culturally sensitive&quot; exercise intervention led to weight loss and other benefits in African-American women with obesity at risk for diabetes, researchers reported.
The program tested in the ongoing, single... (Source: MedPage Today Cardiovascular)</description>
            <author>MedPage Today Cardiovascular</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206798148</guid>        </item>
        <item>
            <title>Obesity is now linked to 32 types of cancer and might be fuelling 40% of cases, shock study warns</title>
            <link>https://medworm.com/1206528128/obesity-is-now-linked-to-32-types-of-cancer-and-might-be-fuelling-40-of-cases-shock-study-warns/</link>
            <description>They warned the 'groundbreaking' research, presented at a medical conference in Italy, which spanned four decades, shows the nation faces a devastating timebomb. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206528128</guid>        </item>
        <item>
            <title>Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually</title>
            <link>https://medworm.com/1206506638/slow-responders-to-zepbound-achieve-meaningful-weight-loss-eventually/</link>
            <description>(MedPage Today) -- NEW ORLEANS -- The vast majority of patients with obesity who responded slowly to the once-weekly injectable tirzepatide (Zepbound) achieved meaningful reductions in body weight a year later, a post hoc analysis of the SURMOUNT... (Source: MedPage Today Endocrinology)</description>
            <author>MedPage Today Endocrinology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206506638</guid>        </item>
        <item>
            <title>Sleeve Gastrectomy Beneficial for Obese Kidney Transplant Candidates</title>
            <link>https://medworm.com/1206537311/sleeve-gastrectomy-beneficial-for-obese-kidney-transplant-candidates/</link>
            <description>FRIDAY, May 10, 2024 -- For kidney transplant (KT) candidates with obesity, sleeve gastrectomy (SG) is effective, and a considerable proportion of patients undergo KT within 20.9 months, according to a study published in the May issue of the Mayo... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206537311</guid>        </item>
        <item>
            <title>Doctors reveal TERRIFYING new psychological side effects caused by Ozempic</title>
            <link>https://medworm.com/1206528134/doctors-reveal-terrifying-new-psychological-side-effects-caused-by-ozempic/</link>
            <description>Case reports of patients taking obesity drugs suggest they have potentially severe psychiatric effects, leading to anxiety and mania as well as suicidal thoughts and attempts. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206528134</guid>        </item>
        <item>
            <title>Targeting Obesity to Improve HFpEF Outcomes Targeting Obesity to Improve HFpEF Outcomes</title>
            <link>https://medworm.com/1206496758/targeting-obesity-to-improve-hfpef-outcomes-targeting-obesity-to-improve-hfpef-outcomes/</link>
            <description>Drs Javed Butler and Mikhail Kosiborod discuss the hypothesis behind the HFpEF trials and potential new treatments for heart failure with preserved ejection fraction.American College of Cardiology &amp; Medscape (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206496758</guid>        </item>
        <item>
            <title>Obesity as a risk factor for adverse outcomes after pedestrian trauma accidents in the pediatric population - Mulvihill H, Roster K, Lakhi N.</title>
            <link>https://medworm.com/1206450239/obesity-as-a-risk-factor-for-adverse-outcomes-after-pedestrian-trauma-accidents-in-the-pediatric-pop/</link>
            <description>OBJECTIVE: The aim of the study is to determine whether overweight or obese children are at an increased risk for injury and adverse outcomes following pedestrian motor vehicle accidents. METHODS: We performed a retrospective study of patients betw... (Source: SafetyLit)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206450239</guid>        </item>
        <item>
            <title>Kids and Anti-Obesity Meds: Real-World Challenges Kids and Anti-Obesity Meds: Real-World Challenges</title>
            <link>https://medworm.com/1206404800/kids-and-anti-obesity-meds-real-world-challenges-kids-and-anti-obesity-meds-real-world-challenges/</link>
            <description>The new anti-obesity drugs could be as beneficial for the treatment of adolescents as adults — but obstacles may require creative strategies.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206404800</guid>        </item>
        <item>
            <title>EVgo's Q1 Performance Sparks Optimism, Analyst Upgrades Stock</title>
            <link>https://medworm.com/1206221742/evgo-s-q1-performance-sparks-optimism-analyst-upgrades-stock/</link>
            <description>Cantor Fitzgerald analyst Andres Sheppard upgraded the shares of EVgo Inc EVGO from Neutral to Overweight and lowered the price target from $5 to $4. EVGO reported a first-quarter FY24 sales jump of 118.2% year-on-year to $55.16 million, beating the analyst consensus estimate of $52.389 million.…#cantorfitzgerald #andressheppard #evgoincevgo #neutral #evgo #olgashevorenkova #yyevgo #plugshare #breakevenadj #nevi (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206221742</guid>        </item>
        <item>
            <title>Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism</title>
            <link>https://medworm.com/1206230769/bariatric-surgery-tied-to-higher-short-term-risk-for-venous-thromboembolism/</link>
            <description>THURSDAY, May 9, 2024 -- In the short term, bariatric surgery is associated with a greater risk for venous thromboembolism (VTE), but in the long-term, it is associated with lower risk, according to a study published online April 30 in&amp;nbsp;Obesity... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206230769</guid>        </item>
        <item>
            <title>The Land That Doesn ’ t Need Ozempic</title>
            <link>https://medworm.com/1206223093/the-land-that-doesn-t-need-ozempic/</link>
            <description>In March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy&amp;mdash;which was in staggering demand across the world, causing shortages everywhere&amp;mdash;had been approved to treat obesity in their country. It sounded, at first glance, like great news for Novo Nordisk, the company that makes Ozempic and Wegovy. But industry outlet the Pharma Letter explained that this would not in fact turn out to be much of a boost. They predicted that these drugs would dominate the market in Japan, but that won&amp;rsquo;t mean much, for a simple reason: there is almost no obesity there. Some 42% of Americans are obese, compared with just 4.5% of Japanese people. Japan, it seems, is the land that doesn&amp;rsquo;t need Ozempic.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




I won...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206223093</guid>        </item>
        <item>
            <title>India's top nutrition institute declares mud pots best utensil for cooking, warns about non-stick pans</title>
            <link>https://medworm.com/1206119692/indias-top-nutrition-institute-declares-mud-pots-best-utensil-for-cooking-warns-about-non-stick-pa/</link>
            <description>The National Institute of Nutrition (NIN) updates dietary guidelines for Indians, emphasizing the use of earthen cookware as safest for cooking due to its eco-friendliness and food preservation qualities. NIN also issues warnings about unsafe storage of acidic foods in metal vessels and overheating non-stick pans. Additionally, guidelines recommend limiting sugar intake, avoiding protein supplements, and promoting healthier dietary habits to combat malnutrition and obesity. (Source: The Economic Times)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>The Economic Times</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206119692</guid>        </item>
        <item>
            <title>New weight loss 'game changer' silences hunger and lasts longer than Ozempic</title>
            <link>https://medworm.com/1206017757/new-weight-loss-game-changer-silences-hunger-and-lasts-longer-than-ozempic/</link>
            <description>An experimental new weight loss surgery performed in North Carolina that helped patients overcome their hunger hormones has the potential to change the way people treat obesity. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206017757</guid>        </item>
        <item>
            <title>New oral diabetes + obesity drug's India sales surge 100%</title>
            <link>https://medworm.com/1206027180/new-oral-diabetes-obesity-drugs-india-sales-surge-100/</link>
            <description>India experiences a surge in Rybelsus sales, impacting the anti-obesity market. Semaglutide dominates, reflecting India's obesity challenges and evolving disease patterns as it grows as a superpower. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206027180</guid>        </item>
        <item>
            <title>Majority of Adults At Risk for CKM Syndrome Majority of Adults At Risk for CKM Syndrome</title>
            <link>https://medworm.com/1205884281/majority-of-adults-at-risk-for-ckm-syndrome-majority-of-adults-at-risk-for-ckm-syndrome/</link>
            <description>The creation of CKM syndrome by the American Heart Association in 2023 aimed to recognize the intricate interplay between heart, kidney diseases, diabetes, and obesity.Medscape Medical News (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205884281</guid>        </item>
        <item>
            <title>Obesity 'game changer' in new procedure that burns lining of the stomach and destroys hunger hormone</title>
            <link>https://medworm.com/1205915513/obesity-game-changer-in-new-procedure-that-burns-lining-of-the-stomach-and-destroys-hunger-hormone/</link>
            <description>An experimental new weight loss surgery performed in North Carolina that helped patients overcome their hunger hormones has the potential to change the way people treat obesity. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205915513</guid>        </item>
        <item>
            <title>MRE-Liver Stiffness Measure Better for Varices in NAFLD Cirrhosis</title>
            <link>https://medworm.com/1205924760/mre-liver-stiffness-measure-better-for-varices-in-nafld-cirrhosis/</link>
            <description>WEDNESDAY, May 8, 2024 -- For patients with obesity and nonalcoholic fatty liver disease (NAFLD) compensated cirrhosis (CC), liver stiffness measurement (LSM) by magnetic resonance elastography (MRE) is significantly higher than acoustic radiation... (Source: Drugs.com - Pharma News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205924760</guid>        </item>
        <item>
            <title>No One Knows How to Talk About Weight Loss Anymore</title>
            <link>https://medworm.com/1205917107/no-one-knows-how-to-talk-about-weight-loss-anymore/</link>
            <description>Jess, 38, has lost 75 pounds since she started taking Wegovy last year. She&amp;#8217;s thrilled with the results&amp;mdash;in addition to losing weight, her blood work and sleep apnea have improved&amp;mdash;but the changes to her life and body feel too fraught to talk about with her friends, who want nothing to do with her weight loss.



Years ago, Jess, who asked to use only her first name for privacy, and her friends embraced the principles of the Health at Every Size movement, which fights against anti-fat bias and argues that weight is not an accurate indicator of health. But last summer, despite her support for that school of thought, Jess decided that she wanted to lose weight to feel better in her body. When she mentioned that decision to her friends, &amp;ldquo;they told me, &amp;lsquo;We have no i...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205917107</guid>        </item>
        <item>
            <title>When'One Size' Doesn't Fit All When'One Size' Doesn't Fit All</title>
            <link>https://medworm.com/1205884283/when-one-size-doesn-t-fit-all-when-one-size-doesn-t-fit-all/</link>
            <description>Treating obesity requires more than a single solution for all patients. Sarah Ro, MD, and Asantewaa Crumpler, MD, discuss taking a more personalized approach with their patients.Medscape Diabetes &amp; Endocrinology (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205884283</guid>        </item>
        <item>
            <title>Symbotic Reports Q1 Beat: Analysts Boost Their 2024 Estimates,'Strong Secular Growth Story '</title>
            <link>https://medworm.com/1205818804/symbotic-reports-q1-beat-analysts-boost-their-2024-estimates-strong-secular-growth-story-/</link>
            <description>Symbotic Inc (NASDAQ:SYM) shares were climbing in early trading on Tuesday, after the company reported a sales beat for its fiscal second quarter. The results were reported amid an exciting earnings season. Here are some key analyst expectations. Analyst Ken Newman maintained an Overweight rating…#symboticinc #sym #kennewman #overweight #newman #greenboxjv #ricchiuti #fq3 #consensus44 #sympriceaction (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205818804</guid>        </item>
        <item>
            <title>Excess Gestational Weight Gain Common in Military Health Beneficiaries</title>
            <link>https://medworm.com/1205736479/excess-gestational-weight-gain-common-in-military-health-beneficiaries/</link>
            <description>TUESDAY, May 7, 2024 -- Military health beneficiaries, especially active-duty personnel, more often have excessive gestational weight gain (GWG), according to a study published in the May issue of Obesity.Rebecca A. Krukowski, Ph.D., from the... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205736479</guid>        </item>
        <item>
            <title>Time-Restricted Eating + High-Intensity Training Aids Women With Obesity, Inactivity</title>
            <link>https://medworm.com/1205736489/time-restricted-eating-high-intensity-training-aids-women-with-obesity-inactivity/</link>
            <description>TUESDAY, May 7, 2024 -- Combining time-restricted eating (TRE) with high-intensity functional training (HIFT) may have superior effects on body composition, lipid profile, and glucose regulation among inactive women with obesity compared with diet... (Source: Drugs.com - Pharma News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205736489</guid>        </item>
        <item>
            <title>Continuous Glucose Monitors Gain Favor in Obesity Continuous Glucose Monitors Gain Favor in Obesity</title>
            <link>https://medworm.com/1205619621/continuous-glucose-monitors-gain-favor-in-obesity-continuous-glucose-monitors-gain-favor-in-obesity/</link>
            <description>The off-label use of CGMs for people possibly on the verge of, but not yet diagnosed with, diabetes is seen as a potential tool to help reverse course; over-the-counter version highly anticipated.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205619621</guid>        </item>
        <item>
            <title>Why Do Some Obesity Interventions Work Longer Than Others? Why Do Some Obesity Interventions Work Longer Than Others?</title>
            <link>https://medworm.com/1205619622/why-do-some-obesity-interventions-work-longer-than-others-why-do-some-obesity-interventions-work-lo/</link>
            <description>The time to weight loss plateau is longer with both GLP-1 receptor agonists and bariatric surgery than with diets alone due to their effect on appetite, not energy expenditure.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205619622</guid>        </item>
        <item>
            <title>Beyond weight loss: Bariatric surgery may reduce cancer risk</title>
            <link>https://medworm.com/1206091985/beyond-weight-loss-bariatric-surgery-may-reduce-cancer-risk/</link>
            <description>When you think about  obesity, you may not connect it to cancer. However, researchers long have suspected a link between certain cancers and weight. Among those are endometrial, ovarian, colon, liver, pancreatic and postmenopausal breast cancers, which together contribute to 15 to 20% of all cancer deaths in the U.S. Cancer risk increases with obesity More than one-third of adults in the U.S. are considered obese with a&amp;nbsp;body mass index (BMI)&amp;nbsp;of 30 or higher. BMI is the&amp;nbsp;measure&amp;hellip; (Source: News from Mayo Clinic)</description>
            <author>News from Mayo Clinic</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1206091985</guid>        </item>
        <item>
            <title>How being obese may protect you from dementia - but only if you're a certain age</title>
            <link>https://medworm.com/1205460116/how-being-obese-may-protect-you-from-dementia-but-only-if-youre-a-certain-age/</link>
            <description>Obesity in middle-age is believed to be a top risk factor for developing dementia, but being obese later in life has been shown have a protective effect against mind-wasting brain diseases. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205460116</guid>        </item>
        <item>
            <title>Investors Pile Into Amgen in Search of Next Obesity Drug Payout</title>
            <link>https://medworm.com/1205371022/investors-pile-into-amgen-in-search-of-next-obesity-drug-payout/</link>
            <description>Investors who may have missed out on the blistering rally in Eli Lilly &amp; Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc. • None France’s Macron Calls for Reset of Economic Ties With China • None Lamborghini Bros No More: Crypto Is Creating a New Wealth Effect The shares…#elilillyco #novonordiskas #amgeninc #macroncalls #amgen #maritide #lilly #novo #unseatlilly #williamblair (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205371022</guid>        </item>
        <item>
            <title>Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update - ARK Genomic Revolution ETF …</title>
            <link>https://medworm.com/1205371152/cathie-wood-s-ark-invest-snaps-up-354m-worth-of-shares-in-this-biopharma-company-following-posit/</link>
            <description>Cathie Wood-run Ark Invest on Friday picked up shares of a biopharma company after it revealed significant progress with its weight-loss drug candidate. What Happened: Ark, through its ARK Genomic Revolution ETF ARKG, bought 11,360 shares of Amgen, Inc. AMGN, which rallied nearly 12% on Friday.…#cathiewoodrun #arkinvest #amgen #arkg #maritide #amg #gip #glp1 #jaybradner #phase2 (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205371152</guid>        </item>
        <item>
            <title>ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms</title>
            <link>https://medworm.com/1205471801/arrs-dartmouth-poster-wins-for-cvd-risk-prediction-potential-using-mammograms/</link>
            <description>A scientific poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes visualized on screening mammograms won the Summa Cum Laude Award at the 124th American Roentgen Ray Society (ARRS) annual meeting.

Produced by Jessica Hitchcock, MD, and researchers from Dartmouth Hitchcock Medical Center in New Hampshire, the poster demonstrated how fat-enlarged nodes may be associated with high CVD risk, type 2 diabetes, and hypertension. In the future, this work could improve risk stratification without additional cost or additional testing.

Jessica Rubino, MD.

“Fat-enlarged axillary lymph nodes visualized on screening mammography may increase the ability to identify women who would benefit from CVD risk reduction strategies and more intensive risk assessment with ...</description>
            <author>AuntMinnie.com Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205471801</guid>        </item>
        <item>
            <title>Interaction of obesity and proteins associated with the NLRP3 inflammasome following mild traumatic brain injury - Eagle SR, Basantani MK, Preszler J, Sherry N, McIntyre P, Kershaw EE, Puccio AM, Okonkwo DO.</title>
            <link>https://medworm.com/1205314067/interaction-of-obesity-and-proteins-associated-with-the-nlrp3-inflammasome-following-mild-traumatic-/</link>
            <description>The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome has been associated with worse outcomes from severe traumatic brain injury (TBI). The NLRP3 inflammasome is also strongly associated with other pro-inflammatory conditions, such a... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205314067</guid>        </item>
        <item>
            <title>' Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem</title>
            <link>https://medworm.com/1205292509/-ozempic-ftw-elon-musk-touts-novo-nordisk-s-blockbuster-drug-as-solution-to-childhood-obesity/</link>
            <description>Tesla and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving his seal of approval for Novo Nordisk‘s NVO Ozempic, a GLP-1 agonist primarily prescribed to manage Type 2 diabetes. What Happened: On Sunday, Musk responded to a post on X about…#tesla #elonmusk #glp1 #calleymeans #billackman #donaldtrump #robertkennedyjr #apple #walmart #novonordisk (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205292509</guid>        </item>
        <item>
            <title>Obesity and low productivity in the UK go hand in hand, think-tank warns</title>
            <link>https://medworm.com/1205300602/obesity-and-low-productivity-in-the-uk-go-hand-in-hand-think-tank-warns/</link>
            <description>IPPR researchers describe government’s ‘laissez-faire’ approach to public health as a ‘failed experiment’ (Source: FT.com - Drugs and Healthcare)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205300602</guid>        </item>
        <item>
            <title>Obesity and low productivity in the UK go hand in hand, warns think-tank</title>
            <link>https://medworm.com/1205378982/obesity-and-low-productivity-in-the-uk-go-hand-in-hand-warns-think-tank/</link>
            <description>IPPR researchers describe government’s laissez-faire approach to public health as a ‘failed experiment’ (Source: FT.com - Drugs and Healthcare)</description>
            <author>FT.com - Drugs and Healthcare</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205378982</guid>        </item>
        <item>
            <title>Ozempic Maker Novo Nordisk Has Denmark ’s Economy Hooked</title>
            <link>https://medworm.com/1205206862/ozempic-maker-novo-nordisk-has-denmark-s-economy-hooked/</link>
            <description>There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global phenomenon. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weight loss drugs, which Goldman Sachs estimates will reach $100 billion a year by 2030. The…#ozempicandwegovy #goldmansachs #novonordisk #denmark #novo #danish #gatesfoundation #ukraine #subscribe #bloombergoriginals (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205206862</guid>        </item>
        <item>
            <title>Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making</title>
            <link>https://medworm.com/1205121627/move-over-mounjaro-eli-lilly-has-another-blockbuster-in-the-making/</link>
            <description>The pharmaceutical industry is currently experiencing something of a renaissance thanks to the rise of blockbuster medications called glucagon-like peptide-1 (GLP-1) agonists. Perhaps the most well-known GLP-1 drugs are diabetes medication Ozempic and obesity care treatment Wegovy. Danish…#glp1 #danish #novonordisk #elililly #lly #fda #lilly #zepbound #jpmorgan #wegovy (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205121627</guid>        </item>
        <item>
            <title>Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?</title>
            <link>https://medworm.com/1205121641/eli-lilly-raised-its-outlook-is-the-stock-a-buy-now/</link>
            <description>The anti-obesity medication stock is way up, and there could be more fuel in the tank. Eli Lilly (LLY -2.77%) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock still has heaps…#elililly #barclay #lilly #tirzepatide #glp1 #gip #novonordisk #vikingtherapeutics (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205121641</guid>        </item>
        <item>
            <title>‘Don’t Count It Out,’ Says Morgan Stanley About AMD Stock</title>
            <link>https://medworm.com/1205035986/dont-count-it-out-says-morgan-stanley-about-amd-stock/</link>
            <description>Is Advanced Micro Devices (NASDAQ:AMD) falling behind in the race for generative AI? Recent investor sentiment suggests so, with the stock taking a hit following the chip giant’s Q1 earnings release. While AMD surpassed expectations in both revenue and earnings in its Q1 report, the outlook didn’t…#advancedmicrodevices #amd #nvidia #fy2024 #gpu #morganstanleys #josephmoore #moore #blackwell #overweight (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1205035986</guid>        </item>
        <item>
            <title>Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market</title>
            <link>https://medworm.com/1204780273/amgen-s-peek-at-its-glp-1-drug-trial-results-heightens-competition-in-obesity-market/</link>
            <description>Amgen&amp;#39;s (AMGN) positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday. CEO Bob Bradway shared a peek at phase II results of the potential competitor to market leaders Wegovy from Novo Nordisk (NVO) and Zepbound from Eli Lilly…#amgen #amgn #glp1 #maritide #bobbradway #wegovy #novonordisk #nvo #elililly #lly (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204780273</guid>        </item>
        <item>
            <title>Here Comes Obesity Drug Competition: Amgen Shares Soar On &quot; Very Encouraging &quot;  Clinical Trial Update</title>
            <link>https://medworm.com/1204691797/here-comes-obesity-drug-competition-amgen-shares-soar-on-very-encouraging-clinical-trial-updat/</link>
            <description>Here Comes Obesity Drug Competition: Amgen Shares Soar On &amp;#34;Very Encouraging&amp;#34; Clinical Trial Update Amgen&amp;#39;s shares soared in premarket trading in New York following the drug maker&amp;#39;s announcement of &amp;#34;very encouraging&amp;#34; clinical trial results for its new injectable weight-loss drug, &amp;#34;MariTide.&amp;#34;…#amgen #maritide #elilillyco #novonordiskaswegovy #robertbradway #bradway #phase2 #barclaysplc #emilyfield #elililly (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204691797</guid>        </item>
        <item>
            <title>Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide</title>
            <link>https://medworm.com/1204691876/amgen-stock-soars-on-weight-loss-injection-progress-as-novo-nordisk-eli-lilly-shares-slide/</link>
            <description>Amgen &amp;#39;s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new competition in the rapidly growing weight loss drug industry, sending shares of the current obesity players, Novo Nordisk…#amgen #novonordisk #elililly #bobbradway #maritide #bradway #jaybradner #wegovyand #williamblair #mattphipps (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204691876</guid>        </item>
        <item>
            <title>Launching an Obesity Medicine Practice? Key Considerations Launching an Obesity Medicine Practice? Key Considerations</title>
            <link>https://medworm.com/1204675791/launching-an-obesity-medicine-practice-key-considerations-launching-an-obesity-medicine-practice-k/</link>
            <description>As the treatment of obesity in the 21st century takes a monumental turn, the need for quality care is more pressing than ever: Tips for starting a new obesity-focused practice.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204675791</guid>        </item>
        <item>
            <title>Small Bowel Microbiome Profiles Differ in Overweight/Obesity Small Bowel Microbiome Profiles Differ in Overweight/Obesity</title>
            <link>https://medworm.com/1204675792/small-bowel-microbiome-profiles-differ-in-overweightobesity-small-bowel-microbiome-profiles-differ-/</link>
            <description>Researchers have identified significant and specific variations in the microbial universe of the small intestine in overweight or obese adults compared with normal-weight peers.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204675792</guid>        </item>
        <item>
            <title>What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks</title>
            <link>https://medworm.com/1204501127/what-is-the-best-weight-loss-stock-to-buy-now-our-top-3-picks/</link>
            <description>Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now According to Harvard University, about two-thirds of United States adults are “overweight or obese,” while 36% are obese. And the university predicts that, at the…#harvarduniversity #lifetimegroup #lifetime #aphase2 #elililly #novonordisk #xponentialfitness #xponential #xpof #cyclebar (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204501127</guid>        </item>
        <item>
            <title>Amgen Soars After CEO Gives Update on Experimental Obesity Drug</title>
            <link>https://medworm.com/1204501302/amgen-soars-after-ceo-gives-update-on-experimental-obesity-drug/</link>
            <description>Amgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide. • None Saudi Arabia Steps Up Arrests Of Those Attacking Israel Online • None Turkey Confirms All Trade Halt…#amgenincs #maritide #gaza #reshapemiddleeast #amgen #robertbradway #thousandoaks #elilillyco #novonordiskas #michaelshah (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204501302</guid>        </item>
        <item>
            <title>Can Unsaturated Fat Boost Muscle in People With Overweight? Can Unsaturated Fat Boost Muscle in People With Overweight?</title>
            <link>https://medworm.com/1204390963/can-unsaturated-fat-boost-muscle-in-people-with-overweight-can-unsaturated-fat-boost-muscle-in-peop/</link>
            <description>High doses of PUFAs didn't differentially affect lean tissue accumulation in middle-aged individuals with overweight, as in the elderly and young lean populations.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204390963</guid>        </item>
        <item>
            <title>Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst</title>
            <link>https://medworm.com/1204409486/joel-habener-dan-drucker-svetlana-mojsov-and-jens-juul-holst/</link>
            <description>Newly powerful weight-loss drugs became the biggest story in health in the past year&amp;mdash;and Dr. Jens Juul Holst, Dr. Joel Habener, Svetlana Mojsov, and Dr. Daniel Drucker played pivotal roles in making those medications possible. The scientists conducted the early work, beginning in the 1970s, on glucagon-like peptides, or GLPs, that first transformed the treatment of diabetes and now that of obesity.&amp;nbsp;
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




As with many groundbreaking medical developments, it was a group effort. Holst, at the University of Copenhagen (where he&amp;rsquo;s now professor of endocrinology and metabolism), noticed that after intestinal surgery, patients&amp;rsquo; levels of insulin soared while their blood-sugar levels dropped; he attributed the changes to several gu...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204409486</guid>        </item>
        <item>
            <title>Does Taking Fish Oil in Pregnancy Raise Child Obesity Risk? Does Taking Fish Oil in Pregnancy Raise Child Obesity Risk?</title>
            <link>https://medworm.com/1204390964/does-taking-fish-oil-in-pregnancy-raise-child-obesity-risk-does-taking-fish-oil-in-pregnancy-raise-/</link>
            <description>Study finds slightly higher risk in children at 10 years, but experts say this shouldn't change current supplementation recommendations.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204390964</guid>        </item>
        <item>
            <title>Novo Nordisk raises outlook fuelled by obesity drug demand</title>
            <link>https://medworm.com/1204308805/novo-nordisk-raises-outlook-fuelled-by-obesity-drug-demand/</link>
            <description>Novo Nordisk raised its 2024 outlook on Thursday and delivered better-than-expected quarterly profits as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from rival Eli Lilly. The small raise to the outlook and forecast-beating…#novonordisk #danish #elililly #wegovy #novo (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204308805</guid>        </item>
        <item>
            <title>Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up</title>
            <link>https://medworm.com/1204675797/novo-nordisk-trims-price-for-blockbuster-obesity-drug-as-competition-heats-up-novo-nordisk-trims-pri/</link>
            <description>Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while competition from rival Eli Lilly...Reuters Health Information (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204675797</guid>        </item>
        <item>
            <title>Weight-loss surgery before kidney transplantation improves health and eligibility of patients with obesity and renal failure, Mayo Clinic study finds</title>
            <link>https://medworm.com/1204879333/weight-loss-surgery-before-kidney-transplantation-improves-health-and-eligibility-of-patients-with-o/</link>
            <description>ROCHESTER, Minn. — Laparoscopic sleeve gastrectomy promotes relatively rapid weight loss, reduces obesity-related health issues and improves eligibility for kidney transplantation for patients with advanced chronic kidney disease and obesity, according to new research from Mayo Clinic. Patients with advanced chron ic kidney failure and severe obesity often are not considered for kidney transplantation, but according to a study published in Mayo Clinic Proceedings, sleeve gastrectomy can improve high-risk patients meeting the criteria for transplantation. The&amp;hellip; (Source: Mayo Clinic Research News)</description>
            <author>Mayo Clinic Research News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204879333</guid>        </item>
        <item>
            <title>So you've lost weight using Wegovy. Does that mean you can stop taking it?</title>
            <link>https://medworm.com/1204210206/so-youve-lost-weight-using-wegovy-does-that-mean-you-can-stop-taking-it/</link>
            <description>Millions of Americans who have used new obesity drugs like Wegovy to lose weight and improve health are wondering what happens if they stop taking them (Source: ABC News: Health)</description>
            <author>ABC News: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204210206</guid>        </item>
        <item>
            <title>Study: Combine intermittent fasting with high-intensity exercise to boost health</title>
            <link>https://medworm.com/1204211075/study-combine-intermittent-fasting-with-high-intensity-exercise-to-boost-health/</link>
            <description>Among inactive women with obesity, combining time-restricted eating with high-intensity exercise may lead to more transformative changes in body composition and cardiometabolic health than either intervention alone. (Source: Health News - UPI.com)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News - UPI.com</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204211075</guid>        </item>
        <item>
            <title>Energy-Restricted Diet Twice Weekly Tops Exercise in T2D Energy-Restricted Diet Twice Weekly Tops Exercise in T2D</title>
            <link>https://medworm.com/1204093647/energy-restricted-diet-twice-weekly-tops-exercise-in-t2d-energy-restricted-diet-twice-weekly-tops-ex/</link>
            <description>Following a medically supervised energy-restricted diet 2 days a week could improve glycemic control in patients with overweight or mild obesity and type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204093647</guid>        </item>
        <item>
            <title>Will Changing the Term Obesity Reduce Stigma? Will Changing the Term Obesity Reduce Stigma?</title>
            <link>https://medworm.com/1203993336/will-changing-the-term-obesity-reduce-stigma-will-changing-the-term-obesity-reduce-stigma/</link>
            <description>A new term is intended to limit negative connotations, but some experts consider it imprecise and difficult to interpret.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203993336</guid>        </item>
        <item>
            <title>Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues</title>
            <link>https://medworm.com/1204010321/lilly-rides-mounjaro-zepbound-to-better-than-expected-1q-profit-despite-supply-issues/</link>
            <description>Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a…#rapidly #elililly #lilly #davidricks #indianapolis #elilillyandco #zepbound #trulicity #mounjaro (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1204010321</guid>        </item>
        <item>
            <title>Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation</title>
            <link>https://medworm.com/1203894275/hypothalamic-obesity-tx-weekly-insulin-under-review-ozempic-price-investigation/</link>
            <description>(MedPage Today) -- Setmelanotide, an investigational melanocortin-4 receptor agonist, reduced body mass index (BMI) by a mean 15% at 16 weeks and 26% at 12 months in people with hypothalamic obesity in a phase II open-label trial. Developer Rhythm... (Source: MedPage Today Endocrinology)</description>
            <author>MedPage Today Endocrinology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203894275</guid>        </item>
        <item>
            <title>Patients Hitting GLP-1 Plateaus? Here's How to Help</title>
            <link>https://medworm.com/1203871312/patients-hitting-glp-1-plateaus-heres-how-to-help/</link>
            <description>(MedPage Today) -- Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) are changing the game in obesity care. In clinical trials, they helped people lose as much as 15 to 20% of their body weight over the course of about a year -- and... (Source: MedPage Today Psychiatry)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Psychiatry</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203871312</guid>        </item>
        <item>
            <title>MICHAEL MOSLEY: How ultra-processed food can put your child's mental health at risk by increasing their risk of obesity, depression and anxiety</title>
            <link>https://medworm.com/1203811256/michael-mosley-how-ultra-processed-food-can-put-your-childs-mental-health-at-risk-by-increasing-th/</link>
            <description>Many shop-bought treats are often packed with lots of sugar and unhealthy fats, writes DR MICHAEL MOSLEY. But here are some clever recipes which won't send your blood sugar levels soaring. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203811256</guid>        </item>
        <item>
            <title>Is Ozempic the New Anti-Inflammatory Wonder Drug?</title>
            <link>https://medworm.com/1203812851/is-ozempic-the-new-anti-inflammatory-wonder-drug/</link>
            <description>Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn&amp;rsquo;s disease as a teenager, the multiple operations she had endured to remove diseased parts of her bowels, and the array of symptoms she suffered with, including nausea, a dozen bowel movements a day, and a total reliance on nutrition obtained through her veins, known as total parenteral nutrition (TPN). Instead of twenty feet of small intestines that most people have, she only had around twenty inches left, and was diagnosed with a condition called short bowel syndrome. We tried a variety of treatments in the ensuing months, but she...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203812851</guid>        </item>
        <item>
            <title>Sanofi introduces diabetes drug Soliqua in India</title>
            <link>https://medworm.com/1203821077/sanofi-introduces-diabetes-drug-soliqua-in-india/</link>
            <description>Sanofi India has launched its diabetes drug Soliqua in India, a once-daily injectable combination drug containing insulin and GLP-1 receptor agonist lixisenatide. The medication is available at a therapy cost of Rs 1,850 per pen and is indicated for adults with obesity and type 2 diabetes to improve glycemic control. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203821077</guid>        </item>
        <item>
            <title>Why Your Breakfast Should Start with a Vegetable</title>
            <link>https://medworm.com/1203612426/why-your-breakfast-should-start-with-a-vegetable/</link>
            <description>Before the pandemic, Barbara Senich, a retiree from Chapel Hill, N.C., was diagnosed with prediabetes, meaning the sugar levels in her blood put her at risk for developing Type 2 diabetes. The source of that blood sugar was sweet foods, grains, and other carbohydrates. She says she thought about them every 30 seconds, leading to constant snacking.



Today, she&amp;rsquo;s cut her cravings and blood sugar partly by changing how she eats. But Senich didn&amp;rsquo;t ditch the carbs. She changed the order in which she has them.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Researchers have recently found that eating certain foods like non-starchy vegetables before carbs may result in lower, healthier blood sugar, compared to having carbs first. Especially at breakfast, these veggie starters also ...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203612426</guid>        </item>
        <item>
            <title>Blunt abdominal trauma in pregnancy: higher rates of severe abdominal injuries - Skochko S, Nahmias J, Lekawa M, Kong A, Schubl S, Swentek L, Grigorian A.</title>
            <link>https://medworm.com/1203535355/blunt-abdominal-trauma-in-pregnancy-higher-rates-of-severe-abdominal-injuries-skochko-s-nahmias-/</link>
            <description>BACKGROUND: Previous studies suggest increased abdominal girth in obese individuals provides a &quot;cushion effect,&quot; against severe abdominal trauma. In comparison, the unique anatomic/physiological condition of pregnancy, such as the upward displacement of or... (Source: SafetyLit)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203535355</guid>        </item>
        <item>
            <title>The associations of physical activity and health-risk behaviors toward depressive symptoms among college students: gender and obesity disparities - Moss S, Zhang X, Taleb ZB, Gu X.</title>
            <link>https://medworm.com/1203535530/the-associations-of-physical-activity-and-health-risk-behaviors-toward-depressive-symptoms-among-col/</link>
            <description>Engaging in health-risk behaviors (HRBs) may be correlated with depressive symptoms among college students, but these relationships require more research. The purpose of this study was to examine the associations of physical activity levels (i.e., light [L... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203535530</guid>        </item>
        <item>
            <title>‘Obese people should opt for a structured programme of diet, exercise &amp; medication’</title>
            <link>https://medworm.com/1203117314/obese-people-should-opt-for-a-structured-programme-of-diet-exercise-amp-medication/</link>
            <description>&quot;Nothing comes without a downside. These molecules do produce significant nausea and vomiting in some people — to the extent that they have to discontinue the medication. Some may develop diarrhoea, some may have severe constipation. Others may not like the way they lose weight—they may feel very shrunken or their face may seem very thinned out. That’s another sort of downside,&quot; says Dr Ambrish Mithal, chairman, endocrinology &amp; diabetes, Max Healthcare, Delhi. (Source: The Economic Times)</description>
            <author>The Economic Times</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203117314</guid>        </item>
        <item>
            <title>1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On</title>
            <link>https://medworm.com/1203019288/1-unstoppable-pharmaceutical-stock-investors-shouldn-t-sleep-on/</link>
            <description>One of the hottest areas in the pharmaceutical space right now is weight loss. Glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound have become staples for treating diabetes and obesity. Eli Lilly (NYSE: LLY) is the developer of Mounjaro and…#glucagon #glp1 #ozempic #elililly #lly #mounjaro #zepbound #lilly #jpmorgan #novonordisk (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203019288</guid>        </item>
        <item>
            <title>Is emotional eating sabotaging your weight-loss efforts?</title>
            <link>https://medworm.com/1203291286/is-emotional-eating-sabotaging-your-weight-loss-efforts/</link>
            <description>You know losing that extra weight would be good for your health. Your health care team talked with you about how obesity increases your risk of other health issues, such as&amp;nbsp;heart disease,&amp;nbsp;diabetes,&amp;nbsp;high blood pressure&amp;nbsp;and certain types of&amp;nbsp;cancer. They even worked out a healthy eating plan, and you want to stick to it. And you do well for many days, but then something upsetting happens, and your first thought is food. Emotional eating is eating to&amp;hellip; (Source: News from Mayo Clinic)</description>
            <author>News from Mayo Clinic</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1203291286</guid>        </item>
        <item>
            <title>Microsoft Q3 Shines Light On'AI Innovation Cycle': Analysts See'Plenty Of Runway For Growth' - Microsof</title>
            <link>https://medworm.com/1202823468/microsoft-q3-shines-light-on-ai-innovation-cycle-analysts-see-plenty-of-runway-for-growth-/</link>
            <description>Technology giant Microsoft Corporation MSFT reported third-quarter financial results that saw revenue and earnings per share beat estimates from analysts. Analysts are praising the company&amp;#39;s growth of artificial intelligence platforms. • Oppenheimer analyst Timothy Horan has an Outperform rating…#oppenheimer #timothyhoran #raymondjames #andrewmarok #goldmansachs #kashrangan #keithweiss #overweight #wedbush #danielives (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202823468</guid>        </item>
        <item>
            <title>Curbing the price of novel diabetes and obesity medications</title>
            <link>https://medworm.com/1202846122/curbing-the-price-of-novel-diabetes-and-obesity-medications/</link>
            <description>The implications of exorbitant prices for new diabetes and obesity therapies are alarming, according to researchers. (Source: Yale Science and Health News)</description>
            <author>Yale Science and Health News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202846122</guid>        </item>
        <item>
            <title>Pre-Ozempic Obesity Drugs: Effective and Budget-Friendly</title>
            <link>https://medworm.com/1202823701/pre-ozempic-obesity-drugs-effective-and-budget-friendly/</link>
            <description>Before there was Ozempic, there were these cost-friendly, safe, and highly effective weight loss drugs. FDA-approved obesity medication like orlistat (Xenical), phentermine/topiramate (Qsymia), and naltrexone/bupropion extended release (Contrave) have been on the market for decades. (Source: WebMD Health)</description>
            <author>WebMD Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202823701</guid>        </item>
        <item>
            <title>3 High-performing Stocks That Could Rip Once Markets Turn Back Up</title>
            <link>https://medworm.com/1202723915/3-high-performing-stocks-that-could-rip-once-markets-turn-back-up/</link>
            <description>With the S&amp;P 500 index, and equities in general, having had their worst run of red days so far this year, almost every stock has seen losses in recent weeks. This includes names of all sizes, and from across all industries; as the reason for the dip, a surprise jump in inflation is effectively bad…#alphabet #keycorp #overweight #jefferies #energy #exxon #pipersandler #ubsgroup #scotiabank #wellsfargo (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202723915</guid>        </item>
        <item>
            <title>Managing Obesity Can Lead to Sarcopenia: A'Hidden' Problem Managing Obesity Can Lead to Sarcopenia: A'Hidden' Problem</title>
            <link>https://medworm.com/1202706868/managing-obesity-can-lead-to-sarcopenia-a-hidden-problem-managing-obesity-can-lead-to-sarcopen/</link>
            <description>Sarcopenic obesity, which is characterized by excess adiposity and muscle loss, is an underestimated and underdiagnosed condition, experts say.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202706868</guid>        </item>
        <item>
            <title>Warning over explosion of strokes in next decade: Analysis projects 50% increase in deadly events amid UK's obesity crisis</title>
            <link>https://medworm.com/1202624929/warning-over-explosion-of-strokes-in-next-decade-analysis-projects-50-increase-in-deadly-events-am/</link>
            <description>Lifestyle factors combined with the ageing population and insufficient action on stroke prevention will see cases rise from 100,000 to 150,000 by 2035, according to analysis by the Stroke Association. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202624929</guid>        </item>
        <item>
            <title>It's a viral-sensation oat smoothie that costs pennies to make and promises to help you lose 40lb in two months. Now our experts put so-called OAT-zempic to the test...</title>
            <link>https://medworm.com/1202525040/its-a-viral-sensation-oat-smoothie-that-costs-pennies-to-make-and-promises-to-help-you-lose-40lb-in/</link>
            <description>Unless you've been living on a desert island, you will have heard of Ozempic, the weight-loss drug hailed as the holy grail for those with type 2 diabetes and now obesity. But have you heard of the latest trend? (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202525040</guid>        </item>
        <item>
            <title>Weight loss impacts risky decisions in obesity - Keweloh B, Terenzi D, Froehlich E, Coricelli C, St ürmer P, Rohmann N, Wietzke-Braun P, Beckmann A, Laudes M, Park SQ.</title>
            <link>https://medworm.com/1202450285/weight-loss-impacts-risky-decisions-in-obesity-keweloh-b-terenzi-d-froehlich-e-coricelli-c-st-/</link>
            <description>BACKGROUND&amp; AIMS: Risky decision making is shaped by individual psychological and metabolic state. Individuals with obesity show not only altered risk behavior, but also metabolic and psychological abnormalities. The aim of the present study was to invest... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202450285</guid>        </item>
        <item>
            <title>A Test Told Me I ’m Basically Made of Plastic. You Probably Are Too</title>
            <link>https://medworm.com/1202526537/a-test-told-me-i-m-basically-made-of-plastic-you-probably-are-too/</link>
            <description>I might like to think of my body as a thing of bone and blood and tissue and water, but as I recently learned, it&amp;rsquo;s also a thing of plastic&amp;mdash;home to an alarming amount of plastic toxins known as bisphenols. Used to manufacture mostly hard, durable plastics&amp;mdash;such as water bottles and takeout containers&amp;mdash;bisphenols are often found in the company of phthalates, which are used to make more flexible plastics such as raincoat linings, vinyl boots, and packing tape. Both types of chemicals are known to be hormone disruptors, leading to numerous health problems, including early puberty, obesity, heart disease, diabetes, and changes in liver function, as well as increased risk of certain cancers, particularly skin, breast, liver, and testicular.&amp;nbsp;
[time-brightcove not-tgx=&amp;...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202526537</guid>        </item>
        <item>
            <title>TikTok to crack down on content that promotes disordered eating and dangerous weight-loss habits</title>
            <link>https://medworm.com/1202425045/tiktok-to-crack-down-on-content-that-promotes-disordered-eating-and-dangerous-weight-loss-habits/</link>
            <description>After weight-loss videos proliferated on TikTok, the app is taking measures to promote positive body image and mental health. Saying it does not want to promote negative body comparisons, TikTok is cracking down on posts about disordered eating, dangerous weight-loss habits and potentially harmful…#tiktok #beijing #bytedance #foryoufeed #adampresser #kelseymartinez #mounjaro #obese #glp1 #michelleyork (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202425045</guid>        </item>
        <item>
            <title>Study identifies driver of liver cancer that could be target for treatment</title>
            <link>https://medworm.com/1202547936/study-identifies-driver-of-liver-cancer-that-could-be-target-for-treatment/</link>
            <description>Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route. (Source: Yale Science and Health News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Yale Science and Health News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202547936</guid>        </item>
        <item>
            <title>Is Nighttime the Best Time for Exercise? Is Nighttime the Best Time for Exercise?</title>
            <link>https://medworm.com/1202408321/is-nighttime-the-best-time-for-exercise-is-nighttime-the-best-time-for-exercise/</link>
            <description>The timing of moderate to vigorous physical activity was associated with a lower risk for mortality and CVD in adults with obesity, including those with type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202408321</guid>        </item>
        <item>
            <title>Revealed: The diet to eat just before you have a flu shot...as study suggests nutrition change could makes vaccines more effective</title>
            <link>https://medworm.com/1202424863/revealed-the-diet-to-eat-just-before-you-have-a-flu-shotas-study-suggests-nutrition-change-could/</link>
            <description>Obese people are more likely to develop severe flu complications, even with vaccines. Researchers found that dieting before getting vaccinated make mice better at fighting off the virus. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202424863</guid>        </item>
        <item>
            <title>Ozempic users are traveling 1,000 MILES to find doses amid shortages of weight loss drug as people scramble to burn fat before summer</title>
            <link>https://medworm.com/1202222038/ozempic-users-are-traveling-1000-miles-to-find-doses-amid-shortages-of-weight-loss-drug-as-people-s/</link>
            <description>Dr Angela Fitch, an obesity medicine expert in New York City , said she has had patients fly in from as far afield as Florida , Virginia and Ohio to fill prescriptions. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202222038</guid>        </item>
        <item>
            <title>What's Going On With Novo Nordisk Stock Today?</title>
            <link>https://medworm.com/1202222147/what-s-going-on-with-novo-nordisk-stock-today/</link>
            <description>The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing Novo Nordisk A/S NVO ‘s pricing strategies, particularly those of its diabetes and obesity medications, Ozempic and Wegovy. Senator Bernie Sanders emphasized the necessity of reducing prices to ensure…#pensions #novonordiskasnvos #berniesanders #novonordisks #elililly #lly #zepbound #kff #obese #medicare (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202222147</guid>        </item>
        <item>
            <title>The body types that raise the risk of colon cancer - which is rising rapidly in young people, according to new study</title>
            <link>https://medworm.com/1202221967/the-body-types-that-raise-the-risk-of-colon-cancer-which-is-rising-rapidly-in-young-people-accord/</link>
            <description>A team of researchers in six countries, including the US and UK, found that people who are generally obese or tall with an 'apple' shape were at an increased risk of colorectal cancer. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202221967</guid>        </item>
        <item>
            <title>More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says</title>
            <link>https://medworm.com/1202121628/more-than-3-million-medicare-patients-could-be-eligible-for-coverage-of-wegovy-to-reduce-heart-disea/</link>
            <description>Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released…#boxesofwegovy #novonordisk #medicare #kff #wegovy #obese #notably #glp1 #wegovyifpartd (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202121628</guid>        </item>
        <item>
            <title>About 3.6 Million Medicare Beneficiaries Could Be Eligible for Wegovy Coverage, Study Shows About 3.6 Million Medicare Beneficiaries Could Be Eligible for Wegovy Coverage, Study Shows</title>
            <link>https://medworm.com/1202153997/about-36-million-medicare-beneficiaries-could-be-eligible-for-wegovy-coverage-study-shows-about-3/</link>
            <description>About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk's weight-loss...Reuters Health Information (Source: Medscape Internal Medicine Headlines)</description>
            <author>Medscape Internal Medicine Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202153997</guid>        </item>
        <item>
            <title>THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush</title>
            <link>https://medworm.com/1202021167/thirteen-new-ozempic-like-drugs-are-coming-in-the-next-few-years-as-part-of-weight-loss-goldrush/</link>
            <description>Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1202021167</guid>        </item>
        <item>
            <title>Sarcopenic obesity defined by the ESPEN and EASO consensus statement in older women: risk of falls and bone mineral density implications - Montalv ão-Sousa TM, Ferreira PA, Colombelli NL, de Carvalho KMB, Blazevich AJ, Lima RM.</title>
            <link>https://medworm.com/1201849228/sarcopenic-obesity-defined-by-the-espen-and-easo-consensus-statement-in-older-women-risk-of-falls-a/</link>
            <description>PURPOSE: To apply the ESPEN-EASO diagnostic criteria for Sarcopenic Obesity (SO) in older women and to assess its association with the risk of falls, fear of falls (FOF), and bone mineral density (BMD). METHODS: After exclusion criteria, 232 women ... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201849228</guid>        </item>
        <item>
            <title>Semaglutide Improves Knee OA Pain, Physical Function Semaglutide Improves Knee OA Pain, Physical Function</title>
            <link>https://medworm.com/1201834612/semaglutide-improves-knee-oa-pain-physical-function-semaglutide-improves-knee-oa-pain-physical-fun/</link>
            <description>Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved knee pain and physical function.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape FamilyMedicine Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201834612</guid>        </item>
        <item>
            <title>Hardwired to eat: what can our dogs teach us about obesity? – podcast</title>
            <link>https://medworm.com/1201862924/hardwired-to-eat-what-can-our-dogs-teach-us-about-obesity-podcast/</link>
            <description>Labradors are known for being greedy dogs, and now scientists have come up with a theory about the genetic factors that might be behind their behaviour. Science correspondent and flat-coated retriever owner Nicola Davis visits Cambridge University to meet Dr Eleanor Raffan and Prof Giles Yeo to find out how understanding this pathway could help us treat the obesity crisis in humansContinue reading... (Source: Guardian Unlimited Science)</description>
            <author>Guardian Unlimited Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201862924</guid>        </item>
        <item>
            <title>It really IS harder to say no to cake when you're fat, finds study of obese volunteers' brains</title>
            <link>https://medworm.com/1201727590/it-really-is-harder-to-say-no-to-cake-when-youre-fat-finds-study-of-obese-volunteers-brains/</link>
            <description>Experts in Canada have discovered that people with a higher BMI really do require a bigger shift in brain activity to choose healthy food over their preferred snack. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201727590</guid>        </item>
        <item>
            <title>GLP-1 RAs: Which Drug for Which Patient? GLP-1 RAs: Which Drug for Which Patient?</title>
            <link>https://medworm.com/1201649812/glp-1-ras-which-drug-for-which-patient-glp-1-ras-which-drug-for-which-patient/</link>
            <description>Obesity specialist Dr Holly Lofton reveals how she chooses the right GLP-1 for each patient, and the importance of staying on label.Medscape Internal Medicine (Source: Medscape General Surgery Headlines)</description>
            <author>Medscape General Surgery Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201649812</guid>        </item>
        <item>
            <title>I'm a healthy woman but I sweat so heavily after a workout, I'm dripping wet. DR MARTIN SCURR replies</title>
            <link>https://medworm.com/1201630156/im-a-healthy-woman-but-i-sweat-so-heavily-after-a-workout-im-dripping-wetdr-martin-scurr-repli/</link>
            <description>I am a recently retired, healthy woman who rarely gets ill. However, I was slightly overweight and I now train about four times a week, but while the extra weight has gone, I sweat really heavily. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201630156</guid>        </item>
        <item>
            <title>Underweight, but Not Obesity, Linked to Glaucoma Progression</title>
            <link>https://medworm.com/1201639714/underweight-but-not-obesity-linked-to-glaucoma-progression/</link>
            <description>(MedPage Today) -- A higher body mass index (BMI) was significantly associated with slower rates of retinal nerve fiber layer change among patients with glaucoma, while those with underweight had significantly faster rates of structural loss, according... (Source: MedPage Today Primary Care)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Primary Care</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201639714</guid>        </item>
        <item>
            <title>Africa ’s Biggest Drugmaker Can Help Ease Obesity Medicine Supply Crunch</title>
            <link>https://medworm.com/1201532819/africa-s-biggest-drugmaker-can-help-ease-obesity-medicine-supply-crunch/</link>
            <description>(Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201532819</guid>        </item>
        <item>
            <title>Weight-Loss Drugs Are Dragging Down Snack Makers ’ Bottom Line</title>
            <link>https://medworm.com/1201436546/weight-loss-drugs-are-dragging-down-snack-makers-bottom-line/</link>
            <description>Are you sure you’re not feeling even a little peckish? For people living with diabetes or obesity — two of the biggest health concerns in the US — the immensely popular group of weight loss medications called GLP-1s can be a miracle drug. But for restaurants, snack brands, alcohol makers, and fast…#glp1s #novonordisksozempic #elilillys #wendys #hershey #molsoncoors #halloffame #simplygoodfoods #chipotle #mcdonalds (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201436546</guid>        </item>
        <item>
            <title>Scientists recommend obese people exercise in the evening instead of mornings</title>
            <link>https://medworm.com/1201438023/scientists-recommend-obese-people-exercise-in-the-evening-instead-of-mornings/</link>
            <description>An eight year study revealed that physical activity between 6pm and midnight was linked to greater health benefits for obese people. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201438023</guid>        </item>
        <item>
            <title>Street Calls of the Week: Netflix downgrade; upgrade for Lockheed Martin By</title>
            <link>https://medworm.com/1201339583/street-calls-of-the-week-netflix-downgrade-upgrade-for-lockheed-martin-by/</link>
            <description>Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: downgrades for Netflix, Crocs and Etsy; upgrade for Lockheed Martin . InvestingPro subscribers always get first dibs on market-moving rating changes. What happened? On Monday, JPMorgan…#netflix #crocs #etsy #lockheedmartin #investingpro #jpmorgan #overweight #ukraine #israel #taiwan (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201339583</guid>        </item>
        <item>
            <title>Let Them Eat … Everything</title>
            <link>https://medworm.com/1201340606/let-them-eat-everything/</link>
            <description>In the age of Ozempic, the “fat activist” Virginia Sole-Smith is inspiring and infuriating her followers. (Source: NYT Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>NYT Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1201340606</guid>        </item>
        <item>
            <title>Inside Novo Nordisk, the Company Behind Ozempic and Wegovy</title>
            <link>https://medworm.com/1200953783/inside-novo-nordisk-the-company-behind-ozempic-and-wegovy/</link>
            <description>Novo Nordisk ’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions. (Source: NYT Health)</description>
            <author>NYT Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200953783</guid>        </item>
        <item>
            <title>Scientists reveal if your body shape puts you at risk of colorectal cancer</title>
            <link>https://medworm.com/1200855173/scientists-reveal-if-your-body-shape-puts-you-at-risk-of-colorectal-cancer/</link>
            <description>Your body shape could be putting you at a higher risk of colorectal cancer, scientists have warned. Colorectal cancer is the second-leading cause of cancer deaths in the United States, according to the American Cancer Society, with roughly 150,000 new cases projected for 2024. Overall, the…#bmi #heinzfreisling #scienceadvances #freisling #ukbiobank #obese (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200855173</guid>        </item>
        <item>
            <title>Time-Restricted Eating Tied to Modest Weight Loss</title>
            <link>https://medworm.com/1200828530/time-restricted-eating-tied-to-modest-weight-loss/</link>
            <description>(MedPage Today) -- Restricting daily eating to a 10-hour window was no silver bullet for boosting weight loss in people with obesity and prediabetes, a small study found.
In the 12-week trial, both time-restricted eating (TRE) and a usual pattern... (Source: MedPage Today Cardiovascular)</description>
            <author>MedPage Today Cardiovascular</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200828530</guid>        </item>
        <item>
            <title>Calories, Not Meal Timing, Key to Weight Loss: Study</title>
            <link>https://medworm.com/1200852357/calories-not-meal-timing-key-to-weight-loss-study/</link>
            <description>FRIDAY, April 19, 2024 -- A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other eating freely -- found no difference in weight loss or other health... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200852357</guid>        </item>
        <item>
            <title>Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says</title>
            <link>https://medworm.com/1200630945/tirzepatide-improves-sleep-apnea-in-patients-with-obesity-drugmaker-says/</link>
            <description>(MedPage Today) -- Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials.
In the SURMOUNT-OSA 1 study... (Source: MedPage Today Cardiovascular)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Cardiovascular</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200630945</guid>        </item>
        <item>
            <title>Baby aged just eight months is seen by NHS obesity clinic - but expert says 'it's not unheard of'</title>
            <link>https://medworm.com/1200658157/baby-aged-just-eight-months-is-seen-by-nhs-obesity-clinic-but-expert-says-its-not-unheard-of/</link>
            <description>The NHS service in Somerset, called Splash, is one of only a few in the country offering under-fours and their families access to dietary and psychological support. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200658157</guid>        </item>
        <item>
            <title>Dr. Mauricio Gonzalez Selects Fastlane as Agency of Record</title>
            <link>https://medworm.com/1200667446/dr-mauricio-gonzalez-selects-fastlane-as-agency-of-record/</link>
            <description>Partnership to Help Expand Dr. Mau's Brand &amp; Health Education Mission NEW YORK, April 18, 2024 /PRNewswire-PRWeb/ -- Dr. Mauricio Gonzalez, best known as Dr. Mau, an award-winning, triple board-certified physician in internal, emergency, and obesity medicine based in New York City, has... (Source: PRWeb: Medical Pharmaceuticals)</description>
            <author>PRWeb:  Medical  Pharmaceuticals</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200667446</guid>        </item>
        <item>
            <title>NHS weight management service offered to under fours</title>
            <link>https://medworm.com/1200558787/nhs-weight-management-service-offered-to-under-fours/</link>
            <description>Severely obese pre-schoolers in Somerset are among the first to receive NHS weight management help. (Source: BBC News | Health | UK Edition)</description>
            <author>BBC News | Health | UK Edition</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200558787</guid>        </item>
        <item>
            <title>Eli Lilly's weight loss drug reduces sleep apnea, study shows</title>
            <link>https://medworm.com/1200361018/eli-lilly-s-weight-loss-drug-reduces-sleep-apnea-study-shows/</link>
            <description>Eli Lilly&amp;#39;s weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three clinical trial, published Wednesday, showed that injections of the drug, either 10 mg or 15 mg, &amp;#34;significantly…#elililly #specificallylilly #zepbound #lilly #jeffemmick #wegovy #fda #novonordisk (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200361018</guid>        </item>
        <item>
            <title>Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea</title>
            <link>https://medworm.com/1200370275/eli-lilly-says-zepbound-can-ease-obstructive-sleep-apnea/</link>
            <description>WEDNESDAY, April 17, 2024 -- Eli Lilly announced Wednesday that in two company trials, Zepbound was found to ease sleep apnea in adults with obesity.First approved to treat obesity by the U.S. Food and Drug Administration last November, the power... (Source: Drugs.com - Pharma News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200370275</guid>        </item>
        <item>
            <title>Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports</title>
            <link>https://medworm.com/1200263415/sleep-apnea-reduced-in-people-who-took-zepbound-eli-lilly-reports/</link>
            <description>The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk ’s Wegovy. (Source: NYT Health)</description>
            <author>NYT Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200263415</guid>        </item>
        <item>
            <title>Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Study</title>
            <link>https://medworm.com/1200262335/lilly-pops-after-weight-loss-drug-succeeds-in-sleep-apnea-study/</link>
            <description>stock popped Wednesday after the company&amp;#39;s weight-loss drug significantly reduced nighttime sleep apnea events in people with obesity. The results bolster Lilly&amp;#39;s argument that lowering a person&amp;#39;s body weight could improve sleep apnea, a condition in which breathing while sleep becomes more…#lilly #elililly #davidsong #tema #hrts #cpap #resmed #leerinkpartners #davidrisinger #temasong (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200262335</guid>        </item>
        <item>
            <title>No, You Don ’ t Need to Chug Olive Oil</title>
            <link>https://medworm.com/1200263729/no-you-don-t-need-to-chug-olive-oil/</link>
            <description>Forget morning coffee. Across the internet, people are broadcasting a different routine: drinking a shot of extra virgin olive oil after they climb out of bed.



Gulping down the oil that&amp;rsquo;s usually reserved for cooking has been a &amp;ldquo;gamechanger,&amp;rdquo; one TikToker said. &amp;ldquo;It gives my body a kickstart,&amp;rdquo; another chimed in. Others claim a shot (or more) of olive oil per day improves their gut health, boosts their metabolism, and makes their skin glow. Even celebrities, like Kourtney Kardashian and Ryan Seacrest, have trumpeted their love of olive oil shots.&amp;nbsp;
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




But are they pouring on the praise for good reason? We asked experts what they think of drinking a shot glass full of straight olive oil.



The health benefits ...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200263729</guid>        </item>
        <item>
            <title>Weight-Loss Drugs Help Sleep Apnea Symptoms</title>
            <link>https://medworm.com/1200263730/weight-loss-drugs-help-sleep-apnea-symptoms/</link>
            <description>Eli Lilly &amp; Co.&amp;rsquo;s weight-loss drug Zepbound improved breathing problems in highly anticipated studies that may convince more insurers to cover the $1,000-a-month treatment. 



In two late-stage trials of patients with obstructive sleep apnea, a condition closely linked to obesity, Zepbound reduced the number of times breathing slowed or stopped during sleep by up to 63% from the baseline, Lilly said in a statement Wednesday. The result topped Jefferies analysts&amp;rsquo; expectations that the trials would likely show a reduction of about 50% to 55%.&amp;nbsp;
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Patients in the 52-week studies also lost up to roughly 20% of their body weight, Lilly said.&amp;nbsp;



Lilly said it plans to share full results from the trials at the American Diab...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200263730</guid>        </item>
        <item>
            <title>Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials</title>
            <link>https://medworm.com/1200259442/weight-loss-drug-zepbound-eases-sleep-apnea-in-company-trials/</link>
            <description>WEDNESDAY, April 17, 2024 -- Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.First approved to treat... (Source: Drugs.com - Daily MedNews)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200259442</guid>        </item>
        <item>
            <title>Some Gut Bugs May Help Lower Your Cholesterol</title>
            <link>https://medworm.com/1200259447/some-gut-bugs-may-help-lower-your-cholesterol/</link>
            <description>WEDNESDAY, April 17, 2024 -- Changes in gut bacteria have been linked to a variety of different diseases, including type 2 diabetes, obesity and inflammatory bowel disease.Now, a new study indicates that gut bacteria also might play a role in a... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200259447</guid>        </item>
        <item>
            <title>Amino Acid Supplement Cuts Liver Risks in PCOS and Obesity Amino Acid Supplement Cuts Liver Risks in PCOS and Obesity</title>
            <link>https://medworm.com/1200248058/amino-acid-supplement-cuts-liver-risks-in-pcos-and-obesity-amino-acid-supplement-cuts-liver-risks-in/</link>
            <description>A proprietary essential amino acid supplement in adolescent girls with obesity and polycystic ovary syndrome improved multiple liver-related outcomes.Medscape Medical News (Source: Medscape Gastroenterology Headlines)</description>
            <author>Medscape Gastroenterology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200248058</guid>        </item>
        <item>
            <title>Tailored lung cancer screening model helps determine nodule follow-up</title>
            <link>https://medworm.com/1200176344/tailored-lung-cancer-screening-model-helps-determine-nodule-follow-up/</link>
            <description>A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT (LDCT) helps clinicians determine how to follow up better than rule-based protocols, researchers have found.

A group led by Zixing Wang, MD, of Peking Union Medical College in Beijing, China, found that a tailored model had a 0% rate of delayed diagnosis of lung cancer at 12-month follow-up. The results were published April 15 in Pulmonology.

Up to half of screened individuals have at least one pulmonary nodule on lung cancer screening, and determining the optimal time for follow-up testing of these nodules can be a challenge, the authors explained.

&quot;[Finding pulmonary nodules on LDCT can be] a gateway to repeated imaging, diagnostic workup, and treatment -- including surgical ...</description>
            <author>AuntMinnie.com Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200176344</guid>        </item>
        <item>
            <title>Nestl é adds sugar to infant milk sold in poorer countries, report finds</title>
            <link>https://medworm.com/1200163122/nestl-adds-sugar-to-infant-milk-sold-in-poorer-countries-report-finds/</link>
            <description>Nestlé, the world’s largest consumer goods company, adds sugar and honey to infant milk and cereal products sold in many poorer countries, contrary to international guidelines aimed at preventing obesity and chronic diseases, a report has found. Campaigners from Public Eye, a Swiss investigative…#publiceye #africa #latinamerica #belgian #nido #cerelac #laurentgaberell #publiceyes #brazil #nigelrollins (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200163122</guid>        </item>
        <item>
            <title>The 3 Best Biotech Stocks to Buy Now: Q2 Edition</title>
            <link>https://medworm.com/1200064047/the-3-best-biotech-stocks-to-buy-now-q2-edition/</link>
            <description>Here are some of the top biotech stocks to buy and hold Some of the hottest opportunities can be found in biotech stocks to buy now. With innovation, mergers and acquisitions, major companies looking to replenish their pipelines ahead of patent expirations, treatments for obesity, aging baby…#agiospharmaceuticals #mds #agio #cantorfitzgerald #kengriffins #paultudorjones #amgen #phase2 #obese #amg (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200064047</guid>        </item>
        <item>
            <title>Brain &amp;  Body: Connecting Depression and Obesity Brain &amp;  Body: Connecting Depression and Obesity</title>
            <link>https://medworm.com/1200024466/brain-body-connecting-depression-and-obesity-brain-body-connecting-depression-and-obesity/</link>
            <description>Discover the relationship between obesity and depression as Roger McIntyre, MD, delves into their impact on mental and physical health.WebMD (Source: Medscape Psychiatry Headlines)</description>
            <author>Medscape Psychiatry Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1200024466</guid>        </item>
        <item>
            <title>The Incretin Impact: A New Era in Metabolic Disease and Obesity Drug Development, Upcoming Webinar Hosted by Xtalks</title>
            <link>https://medworm.com/1199973824/the-incretin-impact-a-new-era-in-metabolic-disease-and-obesity-drug-development-upcoming-webinar-h/</link>
            <description>In this free webinar, learn about incretins and their effects throughout the body. Attendees will learn why the future of incretin drug development will likely expand with different combinations, formulations and disease indications. The featured speakers will discuss how advanced imaging... (Source: PRWeb: Medical Pharmaceuticals)</description>
            <author>PRWeb:  Medical  Pharmaceuticals</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199973824</guid>        </item>
        <item>
            <title>Ozempic Hurts the Fight Against Eating Disorders</title>
            <link>https://medworm.com/1199966166/ozempic-hurts-the-fight-against-eating-disorders/</link>
            <description>It&amp;rsquo;s impossible to escape the soaring popularity of Ozempic and similar drugs these days&amp;mdash;daily headlines, celebrity &amp;ldquo;success&amp;rdquo; stories, and apparent ease in procuring prescriptions (even Costco sells them now) abound. But the cumulative effect of all of this has many experts in the eating disorder field worried about how this might affect their patients. This makes sense&amp;mdash;even for those without eating disorders, these drugs can feel both triggering and enticing. After all, research tells us about 90% of women are dissatisfied with their bodies. This sounds like a quick fix.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Then, I started hearing reports&amp;mdash;first anecdotal, then published&amp;mdash;that some doctors were prescribing weight loss drugs like Ozempic ...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199966166</guid>        </item>
        <item>
            <title>Sugar Substitutes Satisfy Appetite, Blunt Insulin Response Sugar Substitutes Satisfy Appetite, Blunt Insulin Response</title>
            <link>https://medworm.com/1199947568/sugar-substitutes-satisfy-appetite-blunt-insulin-response-sugar-substitutes-satisfy-appetite-blunt/</link>
            <description>Replacing sugar with sweeteners didn't increase appetite and lowered blood glucose levels in adults with overweight and obesity, showed a randomized trial.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199947568</guid>        </item>
        <item>
            <title>A Heretic's View: Blaming Food For Obesity Is Like Blaming Water For Drowning</title>
            <link>https://medworm.com/1199867086/a-heretic-s-view-blaming-food-for-obesity-is-like-blaming-water-for-drowning/</link>
            <description>A Heretic&amp;#39;s View: Blaming Food For Obesity Is Like Blaming Water For Drowning Authored by Edward Archer via RealClearScience, There is a politically expedient but problematic fiction that ‘consensus’ matters in science. Since a million matching opinions do not constitute a fact, a consensus —…#edwardarcher #galileo #ireland #irish #812lbsday #amish #t2dm #norway #soda #hippocrates (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199867086</guid>        </item>
        <item>
            <title>How big is the GLP-1 market? Exploring its growth potential By</title>
            <link>https://medworm.com/1199769331/how-big-is-the-glp-1-market-exploring-its-growth-potential-by/</link>
            <description>GLP-1 receptor agonists are changing the way chronic conditions like type 2 diabetes are managed, but they have also been approved in the United States to treat obesity, resulting in investors assessing the various outcomes if they become more widely adopted. But how big is the market for these…#glp1 #goldmansachs #fatimacodystanford #glp1s #mit #jonathangruber #novonordiskas #medicare #goldman #biotech (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199769331</guid>        </item>
        <item>
            <title>Obesity: Improving Communication About a Sensitive Topic Obesity: Improving Communication About a Sensitive Topic</title>
            <link>https://medworm.com/1199770098/obesity-improving-communication-about-a-sensitive-topic-obesity-improving-communication-about-a-se/</link>
            <description>An endocrinologist and her patient share thoughts on improving communication about obesity and the importance of shared decision-making in weight reduction strategies.Medscape (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199770098</guid>        </item>
        <item>
            <title>Adidas wins double upgrade at Morgan Stanley, thanks to ‘Spezial’ and other shoes</title>
            <link>https://medworm.com/1199671374/adidas-wins-double-upgrade-at-morgan-stanley-thanks-to-spezial-and-other-shoes/</link>
            <description>Morgan Stanley has upgraded Adidas shares to overweight, saying “channel checks point to building positive sentiment and top-line momentum.” (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199671374</guid>        </item>
        <item>
            <title>' Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse</title>
            <link>https://medworm.com/1199671463/-miracle-weight-loss-drugs-could-have-reduced-health-disparities-instead-they-got-worse/</link>
            <description>Wegovy is part of a new generation of weight-loss medications that made some doctors optimistic about reversing longstanding racial and ethnic disparities in obesity. So far, the pricey drugs seem to have made those disparities worse. Science magazine anointed them the “2023 Breakthrough of the…#science #mounjaro #laureneberly #wegovy #fda #medicare #medicaid #rociopereira #denverhealth #blackamericans (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199671463</guid>        </item>
        <item>
            <title>'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse</title>
            <link>https://medworm.com/1199707714/miracle-weight-loss-drugs-could-have-reduced-health-disparities-instead-they-got-worse/</link>
            <description>Ozempic and other drugs raised the possibility of reversing the country's obesity crisis. Doctors are frustrated that they've made health disparities worse. (Source: Los Angeles Times - Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Los Angeles Times - Science</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199707714</guid>        </item>
        <item>
            <title>Diabetes symptom warning as pharmacist reveals five signs to watch out for</title>
            <link>https://medworm.com/1199575344/diabetes-symptom-warning-as-pharmacist-reveals-five-signs-to-watch-out-for/</link>
            <description>Pharmacist Graham Phillips is warning that the obesity epidemic is leading to a surge in prediabetes numbers. (Source: Daily Express - Health)</description>
            <author>Daily Express - Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199575344</guid>        </item>
        <item>
            <title>New study to test long-term effects of weight loss drugs</title>
            <link>https://medworm.com/1199327529/new-study-to-test-long-term-effects-of-weight-loss-drugs/</link>
            <description>Ozempic, Wegovy, Mounjaro — three new medications used to treat obesity — seemed to be all over the news and social media in 2023. You’ve likely seen or read about their effectiveness, their side effects, their cost and what happens when you quit taking them. But as we grapple with the increasing epidemic of obesity an d its complementary health issues, researchers at Wake Forest University School of Medicine are looking to an older, generic drug for answers.

First approved by the Food and… (Source: bizjournals.com Health Care:Biotechnology headlines)</description>
            <author>bizjournals.com Health Care:Biotechnology headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199327529</guid>        </item>
        <item>
            <title>Nvidia Leads 5 Stocks Near Buy Points As S &amp; P 500 Tests Key Level</title>
            <link>https://medworm.com/1199183119/nvidia-leads-5-stocks-near-buy-points-as-s-p-500-tests-key-level/</link>
            <description>and uranium producer Cameco (CCJ) lead this weekend&amp;#39;s watch list of five stocks near buy points. Both NVDA and CCJ bucked the trend over the past week as the S&amp;P 500 slipped back to its 50-day moving average for the first time since early November. The list also includes obesity drug leader Novo…#nvda #novonordisk #nvo #aresmanagement #nvidia #ibdleaderboard #swingtrader #ibdstockcheckup #treasury #intel (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1199183119</guid>        </item>
        <item>
            <title>Endoscopic Sleeve Gastroplasty Is Cost Saving Versus Semaglutide</title>
            <link>https://medworm.com/1198995129/endoscopic-sleeve-gastroplasty-is-cost-saving-versus-semaglutide/</link>
            <description>FRIDAY, April 12, 2024 -- For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA Network Open.Muhammad Haseeb, M.D., from Brigham... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198995129</guid>        </item>
        <item>
            <title>Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+</title>
            <link>https://medworm.com/1198906779/surgery-may-be-more-cost-effective-than-wegovy-in-adults-with-a-bmi-35/</link>
            <description>(MedPage Today) -- A certain type of bariatric surgery may prove more cost-effective over time than a popular weight loss drug, an economic evaluation study suggested.
In an analysis of adults with class II obesity (BMI 35-39.9), endoscopic sleeve... (Source: MedPage Today Surgery)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Surgery</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198906779</guid>        </item>
        <item>
            <title>Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says</title>
            <link>https://medworm.com/1198886940/novo-nordiskeli-lilly-s-weight-loss-drugs-does-not-cause-suicidal-behaviors-after-fda-european/</link>
            <description>The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has determined that there is no substantial evidence supporting a link between Glucagon-Like Peptide-1 receptor agonists (GLP-1) and suicidal or self-injurious thoughts and behaviors. The assessment comes following…#glp1 #fda #obese #saxenda #xultophy #sanofisas #snylyxumia #suliqua #elilillyand #cosllytrulicity (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198886940</guid>        </item>
        <item>
            <title>Semaglutide Benefits in HFpEF Step Beyond Weight Loss Semaglutide Benefits in HFpEF Step Beyond Weight Loss</title>
            <link>https://medworm.com/1198859687/semaglutide-benefits-in-hfpef-step-beyond-weight-loss-semaglutide-benefits-in-hfpef-step-beyond-weig/</link>
            <description>Drs Pi ña and Kosiborod discuss semaglutide in obesity-related HF with and without diabetes. Both STEP HFpEF trials show similar HF benefits despite less weight loss in patients with diabetes.theheart.org on Medscape (Source: Medscape Cardiology Headlines)</description>
            <author>Medscape Cardiology Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198859687</guid>        </item>
        <item>
            <title>Average size of women's butts around the world revealed: US fails to crack top 5 and UK is nowhere near top</title>
            <link>https://medworm.com/1198886572/average-size-of-womens-butts-around-the-world-revealed-us-fails-to-crack-top-5-and-uk-is-nowhere-n/</link>
            <description>America has a reputation for plastic surgery and obesity, but South African women have the biggest backsides, data collected by market research company GitNux found. The US took sixth place. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198886572</guid>        </item>
        <item>
            <title>Is it better to workout before or after work? Fitness experts reveal the part of the day when you'll burn the most calories</title>
            <link>https://medworm.com/1198689141/is-it-better-to-workout-before-or-after-work-fitness-experts-reveal-the-part-of-the-day-when-youll/</link>
            <description>A major new study showed that exercising at night reduced obese peoples risk of death by over 60 percent, and risk of heart disease by over 36 percent. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198689141</guid>        </item>
        <item>
            <title>Why a New Study Dubbed India the ‘Cancer Capital of the World’</title>
            <link>https://medworm.com/1198395938/why-a-new-study-dubbed-india-the-cancer-capital-of-the-world/</link>
            <description>A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it &amp;ldquo;the cancer capital of the world.&amp;rdquo;
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Despite reporting more than a million new cases every year, India&amp;rsquo;s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S., reporting 100 cases for every 100,000 people compared with 300 in the U.S.&amp;nbsp;



But that could soon change due to what some experts have called an &amp;ldquo;epidemiolo...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198395938</guid>        </item>
        <item>
            <title>Should I Take Supplements to Sleep? What Experts Think</title>
            <link>https://medworm.com/1198395941/should-i-take-supplements-to-sleep-what-experts-think/</link>
            <description>If you want to understand the importance of sleep, ask someone who spent the previous night tossing and turning. Sleep is a vital function: essential for physical recovery, preparing for the next day, even clearing waste material from the brain. Mounting evidence suggests that getting adequate amounts of sleep each night is even more critical than previously believed, responsible for reducing the risk of serious conditions including dementia, obesity, and stroke.



[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]

Yet so many of us struggle to fall and stay asleep, with more than one-third of U.S. adults failing to get the recommended seven to nine hours of shuteye each night, according to a 2020 survey from the National Sleep Foundation.



Many people are turning to over-the-counter solutio...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198395941</guid>        </item>
        <item>
            <title>Bargain Alert: Apple Shares Are Starting To Look Undervalued - Apple (NASDAQ:AAPL), Amazon.com (NASDAQ:AM</title>
            <link>https://medworm.com/1198199773/bargain-alert-apple-shares-are-starting-to-look-undervalued-apple-nasdaqaapl-amazoncom-nasd/</link>
            <description>It&amp;#39;s been a funny couple of months for shares of Apple Inc AAPL. Traditionally, one of the market leaders who you could nearly bet would be moving in lock-step with the likes of Meta Platforms META or Amazon.com Inc AMZN, this year has seen the iPhone maker&amp;#39;s fortunes diverge significantly from…#appleincaapl #metaplatforms #iphone #apple #amazon #meta #shermanact #timcook #motherofallai #overweight (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198199773</guid>        </item>
        <item>
            <title>The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again</title>
            <link>https://medworm.com/1198197526/the-dying-brain-obesity-drugs-and-ms-nurown-tries-again/</link>
            <description>(MedPage Today) -- New research about the dying brain suggested the line between consciousness and death may not be distinct. (The Guardian)
A single fecal microbiota transplantation induced mild but sustained effects on motor symptoms in early... (Source: MedPage Today Neurology)</description>
            <author>MedPage Today Neurology</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198197526</guid>        </item>
        <item>
            <title>Managing Obesity: More Than GLP-1s or Bust Managing Obesity: More Than GLP-1s or Bust</title>
            <link>https://medworm.com/1198085428/managing-obesity-more-than-glp-1s-or-bust-managing-obesity-more-than-glp-1s-or-bust/</link>
            <description>Obesity expert Dr Holly Lofton reviews three alternatives to GLP-1s to help patients drop excess weight.Medscape Internal Medicine (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198085428</guid>        </item>
        <item>
            <title>America ’ s Growing Birthweight Crisis</title>
            <link>https://medworm.com/1198104220/america-s-growing-birthweight-crisis/</link>
            <description>Americans are increasingly at risk of having lower incomes, poorer health, and a worse shot at opportunity even before they are born. More babies are now born with low birthweights than in the last 30 years. This has caused growing inequalities that can persist if not properly addressed. In certain parts of the country, that risk may be ten-times greater. 









Underweight newborns are at an increased risk of long term health challenges, lower IQ scores, and developmental delays. New data shows that the frequency of this problem is rising with more than 300,000 newborns now experiencing low birthweight. This public health and equity issue is increasingly common in low-income communities, communities with poor access to healthy foods, and homes that are near high-polluting sites.&amp;nbsp;
...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198104220</guid>        </item>
        <item>
            <title>ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes</title>
            <link>https://medworm.com/1198111996/acc-semaglutide-beneficial-in-obesity-related-heart-failure-type-2-diabetes/</link>
            <description>TUESDAY, April 9, 2024 -- Semaglutide leads to larger reductions in heart failure-related symptoms and physical limitations among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198111996</guid>        </item>
        <item>
            <title>What Experts Really Think About Diet Soda</title>
            <link>https://medworm.com/1198104222/what-experts-really-think-about-diet-soda/</link>
            <description>Growing up, Olivia Dreizen Howell, 39, &amp;ldquo;lived on&amp;rdquo; diet soda. So did her family. At a family reunion in 1996, everyone sported T-shirts with their shared surname in Diet Coke-can font. &amp;ldquo;We drank Diet Coke, Diet ginger ale, and Diet Sprite like water&amp;mdash;there was no difference in our household,&amp;rdquo; she says.



Like many, Howell believed that sugar-free soda was a benign choice. But the latest research casts doubt on that assumption, linking diet drinks to mood disorders, fatty liver development, autoimmune diseases, and cancer, to name a few.&amp;nbsp;
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Before you pour your diet soda down the drain (a step one health expert does, in fact, recommend), know this about diet-soda research: the vast majority of it is observation...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198104222</guid>        </item>
        <item>
            <title>Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?</title>
            <link>https://medworm.com/1198005265/can-altimmune-get-its-glp-1-drug-to-market-before-cash-rush-out/</link>
            <description>Altimmune Inc. NASDAQ: ALT is a clinical-stage biotechnology company specializing in treating liver disease and obesity. Their lead drug, Pemvidutide, has garnered much attention as a GLP-1/glucagon dual agonist similar to the weight-loss treatments Mounjaro and Zepbound by Eli Lilly and Co. NYSE:…#altimmuneinc #alt #pemvidutide #glp1 #mounjaro #elilillyandco #lly #ozempicandwegovy #novonordiskasnyse #nvo (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1198005265</guid>        </item>
        <item>
            <title>Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients</title>
            <link>https://medworm.com/1197917489/roswell-park-research-debunks-perceived-benefits-of-overweightobesity-in-lung-cancer-patients/</link>
            <description>Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a lower risk of disease recurrence and longer... (Source: PRWeb: Medical Pharmaceuticals)</description>
            <author>PRWeb:  Medical  Pharmaceuticals</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197917489</guid>        </item>
        <item>
            <title>Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost?</title>
            <link>https://medworm.com/1197820440/medicare-can-cover-anti-obesity-drugs-for-heart-disease-but-at-what-cost/</link>
            <description>(MedPage Today) -- On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks -- heart attack, stroke, and death -- for obese or overweight adults with a history of cardiovascular disease, making it the first... (Source: MedPage Today Primary Care)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedPage Today Primary Care</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197820440</guid>        </item>
        <item>
            <title>WHOLE PERSON INTEGRATIVE EATING ® Launches New Podcast, &quot;The Healing Secrets of Food Revealed,&quot; to Provide Science-Backed Weight-Loss Wisdom</title>
            <link>https://medworm.com/1197819988/whole-person-integrative-eating-launches-new-podcast-the-healing-secrets-of-food-revealed-to-/</link>
            <description>Adding scientifically sound strategies to the weight-loss conversation AUSTIN, Texas, April 8, 2024 /PRNewswire-PRWeb/ -- WHOLE PERSON INTEGRATIVE EATING®, the breakthrough program that identifies and treats the root causes of overeating and overweight, is excited to announce the launch... (Source: PRWeb: Medical Pharmaceuticals)</description>
            <author>PRWeb:  Medical  Pharmaceuticals</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197819988</guid>        </item>
        <item>
            <title>How anti-obesity medications can help with surgery</title>
            <link>https://medworm.com/1197834168/how-anti-obesity-medications-can-help-with-surgery/</link>
            <description>Yale surgeons discuss the potential benefits of taking anti-obesity medications before and sometimes after total joint replacement or bariatric surgery. (Source: Yale Science and Health News)</description>
            <author>Yale Science and Health News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197834168</guid>        </item>
        <item>
            <title>Actually, It ’ s OK to Slouch</title>
            <link>https://medworm.com/1197812390/actually-it-s-ok-to-slouch/</link>
            <description>One of the latest and surprising findings in the field of physical therapy is that slouching is not as bad as we think it is. Certain researchers have gone so far as to say that the conventional fear mongering regarding poor posture can actually be more harmful than slouching itself.&amp;nbsp; Undoing over a century&amp;rsquo;s worth of public health messaging about the evils of poor posture&amp;mdash;let alone the custom of elders telling youngsters to &amp;ldquo;sit up straight&amp;rdquo;&amp;mdash;will be a monumental task.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




I know because I&amp;rsquo;ve spent the better part of a decade researching the so-called &amp;#8220;poor posture epidemic&amp;#8221; of the 20th century, studying the myriad ways in which posture panic has become part of the fabric of our everyday lives...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197812390</guid>        </item>
        <item>
            <title>Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide</title>
            <link>https://medworm.com/1197793725/prior-anti-obesity-drug-use-curbs-weight-loss-on-semaglutide-prior-anti-obesity-drug-use-curbs-weigh/</link>
            <description>Patients who were overweight or obese lost more weight taking semaglutide if they hadn't previously taken another anti-obesity medication.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197793725</guid>        </item>
        <item>
            <title>Do Adults With Obesity Feel Pain More Intensely? Do Adults With Obesity Feel Pain More Intensely?</title>
            <link>https://medworm.com/1197697094/do-adults-with-obesity-feel-pain-more-intensely-do-adults-with-obesity-feel-pain-more-intensely/</link>
            <description>Adults with excess weight or obesity reported higher pain levels, emphasizing the need to address obesity in pain management, according to a systematic review and meta-analysis.Medscape Medical News (Source: Medscape Diabetes Headlines)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197697094</guid>        </item>
        <item>
            <title>Gut Bacteria's Influence on Obesity Differs in Men and Women Gut Bacteria's Influence on Obesity Differs in Men and Women</title>
            <link>https://medworm.com/1197697095/gut-bacteria-s-influence-on-obesity-differs-in-men-and-women-gut-bacteria-s-influence-on-obesity/</link>
            <description>Different bacterial species affect the onset and development of obesity in men vs women.Medscape Medical News (Source: Medscape Diabetes Headlines)</description>
            <author>Medscape Diabetes Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197697095</guid>        </item>
        <item>
            <title>Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot</title>
            <link>https://medworm.com/1197723482/weight-loss-medicines-biocon-eyes-a-100-billion-jackpot-with-weighty-pivot/</link>
            <description>Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market. (Source: The Economic Times Healthcare and Biotech News)</description>
            <author>The Economic Times Healthcare and Biotech News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197723482</guid>        </item>
        <item>
            <title>Semaglutide Beneficial in HFpEF Patients With Diabetes Semaglutide Beneficial in HFpEF Patients With Diabetes</title>
            <link>https://medworm.com/1197649565/semaglutide-beneficial-in-hfpef-patients-with-diabetes-semaglutide-beneficial-in-hfpef-patients-with/</link>
            <description>In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)</description>
            <author>Medscape Internal Medicine Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197649565</guid>        </item>
        <item>
            <title>Wegovy Helps HFpEF Patients With Diabetes Mellitus</title>
            <link>https://medworm.com/1197590256/wegovy-helps-hfpef-patients-with-diabetes-mellitus/</link>
            <description>(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)</description>
            <author>MedPage Today Cardiovascular</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197590256</guid>        </item>
        <item>
            <title>UltraCon: How reliable is POCUS for pancreatic imaging?</title>
            <link>https://medworm.com/1197630251/ultracon-how-reliable-is-pocus-for-pancreatic-imaging/</link>
            <description>AUSTIN, TX – Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change, according to a presentation given April 7 at UltraCon.

In her talk, Alice Lee, MD, from Stanford University in California highlighted findings on how POCUS can be a reliable tool for pancreatic imaging, whether performed by experienced or novice sonographers.

“One of the big implications of pancreatic POCUS is the way that we put imaging in the hands of a provider who’s really managing the patient, whether it’s the gastroenterologist or the primary care physician,” Lee said.

Alice Lee, MD, from Stanford University presents research on the feasibility and performance of point-of-care ultrasound (POCUS) at UltraCon.Amerigo AllegrettoPOCUS has gained trac...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>AuntMinnie.com Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197630251</guid>        </item>
        <item>
            <title>Study shows Wegovy easing heart failure symptoms for patients with diabetes</title>
            <link>https://medworm.com/1197326841/study-shows-wegovy-easing-heart-failure-symptoms-for-patients-with-diabetes/</link>
            <description>Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity. Patients who took Wegovy reported less fatigue, less leg swelling, were…#novonordiskas #novo #danish #jama (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197326841</guid>        </item>
        <item>
            <title>Wegovy ’s heart benefits are not just linked with weight loss, new study suggests</title>
            <link>https://medworm.com/1197326843/wegovy-s-heart-benefits-are-not-just-linked-with-weight-loss-new-study-suggests/</link>
            <description>People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication, according to new research. (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197326843</guid>        </item>
        <item>
            <title>Gestational Weight Gain Below IOM Recommendation Safe in Obesity</title>
            <link>https://medworm.com/1197142337/gestational-weight-gain-below-iom-recommendation-safe-in-obesity/</link>
            <description>FRIDAY, April 5, 2024 -- Gestational weight gain below the current U.S. Institute of Medicine (IOM) recommendation is safe for pregnancies with obesity, according to a study published online March 28 in The Lancet.Kari Johansson, Ph.D., from... (Source: Drugs.com - Pharma News)</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197142337</guid>        </item>
        <item>
            <title>Why Heart Disease Research Still Favors Men</title>
            <link>https://medworm.com/1197037747/why-heart-disease-research-still-favors-men/</link>
            <description>Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women&amp;rsquo;s issues around the world.



Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. &amp;ldquo;I was dizzy. I couldn&amp;rsquo;t breathe. I had heart pain,&amp;rdquo; Fitzgerald says.



She knew she was having a heart attack.
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




What she didn&amp;rsquo;t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to stop the buildup of plaque in her arteries that caused the heart attack and two others that followed.



Fitzgerald&amp;rsquo;s case illustrates a dangerous gap in medical car...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197037747</guid>        </item>
        <item>
            <title>Candace Owens calls Meghan McCain &quot; clinically obese &quot;</title>
            <link>https://medworm.com/1196938584/candace-owens-calls-meghan-mccain-clinically-obese-/</link>
            <description>Candace Owens called Meghan McCain &amp;#34;clinically obese&amp;#34; after getting into a spat with her husband, Ben Domenech, on social media. The Spectator World editor-at-large Domenech on Thursday accused Owens of &amp;#34;blood libel&amp;#34; over a post she recently liked on X, formerly Twitter, that suggested a rabbi was…#candaceowens #meghanmccain #bendomenech #spectatorworld #christian #davesmith #dailywire #israel #benshapiro #hamas (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196938584</guid>        </item>
        <item>
            <title>Nerve Zap Treatment for Sleep Apnea Less Effective in Obese People</title>
            <link>https://medworm.com/1197033571/nerve-zap-treatment-for-sleep-apnea-less-effective-in-obese-people/</link>
            <description>FRIDAY, April 5, 2024 -- Obese folks are less likely to benefit from a nerve-stimulation treatment for sleep apnea that&amp;rsquo;s recently been made available to them, a new study reports. 
The treatment is likely to be 75% less effective among obese... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197033571</guid>        </item>
        <item>
            <title>Weight Loss in Short-Term Interventions for Physical Activity and Nutrition Among Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis</title>
            <link>https://medworm.com/1196768830/weight-loss-in-short-term-interventions-for-physical-activity-and-nutrition-among-adults-with-overwe/</link>
            <description>(Source: CDC Preventing Chronic Disease)</description>
            <author>CDC Preventing Chronic Disease</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196768830</guid>        </item>
        <item>
            <title>Scientists Find New Genetic Variants for Obesity</title>
            <link>https://medworm.com/1196745542/scientists-find-new-genetic-variants-for-obesity/</link>
            <description>Researchers believe they have discovered a new biological mechanism for obesity, pointing to rare variants on two genes that dramatically increase the risk of carrying excess weight. 



Research published in the journal Nature Genetics on Thursday points to variants that raise the chance of being obese by as much as six times. Unlike other known variants that affect weight gain in children, these only appear to play a role in adults. 
[time-brightcove not-tgx=&amp;#8221;true&amp;#8221;]




Unraveling obesity&amp;rsquo;s mechanisms could help scientists develop new drugs, or tailor existing ones, for a condition that now affects&amp;nbsp;one in eight people. For the first time, patients can now take highly effective medicines to shed unwanted weight. The revolution, led by drugmakers Novo Nordisk A/S and...</description>
            <author>TIME: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196745542</guid>        </item>
        <item>
            <title>Obese Pregnant Women Share Stories of Challenging Childhoods</title>
            <link>https://medworm.com/1196707610/obese-pregnant-women-share-stories-of-challenging-childhoods/</link>
            <description>Is there a direct correlation between weight and a difficult childhood in some adults (Source: Disabled World)</description>
            <author>Disabled World</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196707610</guid>        </item>
        <item>
            <title>Veteran strategist says grab your hammer and pick</title>
            <link>https://medworm.com/1196647039/veteran-strategist-says-grab-your-hammer-and-pick/</link>
            <description>Investors need an “aggressive” overweight for gold, says the president of Rosenberg Research, David Rosenberg.#rosenbergresearch #davidrosenberg (Source: Reuters: Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; Have you tried our new &lt;a href=&quot;https://medworm.com/&quot;&gt;medical search engine&lt;/a&gt;? More powerful than before. 100% free.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196647039</guid>        </item>
        <item>
            <title>Rare Genes Can Raise Odds for Obesity 6-Fold</title>
            <link>https://medworm.com/1196741222/rare-genes-can-raise-odds-for-obesity-6-fold/</link>
            <description>THURSDAY, April 4, 2024 -- Two newly discovered genetic variations can have a powerful effect on a person&amp;rsquo;s risk for obesity, a new report says. 
Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold,... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196741222</guid>        </item>
        <item>
            <title>Danone CEO downplays threat of weight loss drugs on food producers:'We see ourselves as extremely complementary '</title>
            <link>https://medworm.com/1196647118/danone-ceo-downplays-threat-of-weight-loss-drugs-on-food-producers-we-see-ourselves-as-extremely-/</link>
            <description>The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime. Antoine de Saint-Affrique said that surging demand for drugs like Wegovy and Mounjaro…#danone #charlottereed #glp1s (Source: Reuters: Health)</description>
            <author>Reuters: Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196647118</guid>        </item>
        <item>
            <title>Scientists find new 'fat genes' that make you six times more likely to be obese - and up to 10,000 Brits carry them</title>
            <link>https://medworm.com/1196646869/scientists-find-new-fat-genes-that-make-you-six-times-more-likely-to-be-obese-and-up-to-10000-b/</link>
            <description>Researchers at the University of Cambridge also found the genetic quirk was linked with an increased risk of non-alcoholic fatty liver disease and of type 2 diabetes. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196646869</guid>        </item>
        <item>
            <title>Newly Discovered Genetic Variants Could Increase Obesity Risk Six-Fold, Study Suggests</title>
            <link>https://medworm.com/1197626055/newly-discovered-genetic-variants-could-increase-obesity-risk-six-fold-study-suggests/</link>
            <description>The primary variation discussed in the study is rare, as it only affects one in 6,500 adults —but it could reveal a new way that genetics impact obesity. (Source: Forbes.com Healthcare News)</description>
            <author>Forbes.com Healthcare News</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1197626055</guid>        </item>
        <item>
            <title>Bowel cancer deaths and cases to soar by a TENTH in by 2040 amid spiralling obesity rates, charity warns</title>
            <link>https://medworm.com/1196549208/bowel-cancer-deaths-and-cases-to-soar-by-a-tenth-in-by-2040-amid-spiralling-obesity-rates-charity-w/</link>
            <description>Analysis released by the Bowelbabe Fund - set up in memory of Deborah James - projected that if current trends continue, bowel cancer cases will rise to 47,700. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Message:&lt;/i&gt;&lt;/b&gt; &lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196549208</guid>        </item>
        <item>
            <title>Prue Leith slams junk food 'cartel' for fuelling Britain's 'unstoppable' obesity crisis and criticises ministers for not restricting sale of biscuits, cakes and crisps</title>
            <link>https://medworm.com/1196451480/prue-leith-slams-junk-food-cartel-for-fuelling-britains-unstoppable-obesity-crisis-and-criticis/</link>
            <description>The Great British Bake Off also slammed the Government for lacking 'the bottle' to run a plan to reverse the effects of junk food. (Source: the Mail online | Health)</description>
            <author>the Mail online | Health</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196451480</guid>        </item>
        <item>
            <title>Association of anthropometric measures with all-cause and cause-specific mortality in US adults: revisiting the obesity paradox - Li S, Fu Z, Zhang W.</title>
            <link>https://medworm.com/1196379895/association-of-anthropometric-measures-with-all-cause-and-cause-specific-mortality-in-us-adults-rev/</link>
            <description>OBJECTIVE: Previous studies have shown that the obesity paradox exists in a variety of clinical settings, whereby obese individuals have lower mortality than their normal-weight counterparts. It remains unclear whether the association between obesity and m... (Source: SafetyLit)</description>
            <author>SafetyLit</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196379895</guid>        </item>
        <item>
            <title>Germs in Your Gut Could Sway Your Odds for Obesity</title>
            <link>https://medworm.com/1196448899/germs-in-your-gut-could-sway-your-odds-for-obesity/</link>
            <description>WEDNESDAY, April 3, 2024 -- Research into germs that travel through the human digestive tract shows that some may promote obesity while others might help prevent it.Not only that, but those microbes may act differently in men versus women, the same... (Source: Drugs.com - Daily MedNews)</description>
            <author>Drugs.com - Daily MedNews</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196448899</guid>        </item>
        <item>
            <title>How Abdominal Fibrogenesis Affects Adolescents With Obesity How Abdominal Fibrogenesis Affects Adolescents With Obesity</title>
            <link>https://medworm.com/1196355313/how-abdominal-fibrogenesis-affects-adolescents-with-obesity-how-abdominal-fibrogenesis-affects-adole/</link>
            <description>Abdominal fibrogenesis increased significantly, while the adipose tissue expandability remained unaffected in insulin-resistant adolescents with obesity.Medscape Medical News (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
            <pubDate>Thu, 06 Jun 2024 18:59:50 +0100</pubDate>
            <guid isPermaLink="false">1196355313</guid>        </item>
    </channel>
</rss>
